https://curecurrent.com/trials/a-dose-escalation-and-expansion-study-of-lomvastomig-a-pd-1-tim-3-bispecific-antibody-in-participants-with-advanced-and-45001https://curecurrent.com/trials/study-of-iparomlimab-and-tuvonralimab-plus-chemotherapy-in-malignant-mesothelioma-45002https://curecurrent.com/trials/aliya-pulsed-electric-fields-pef-for-advanced-cancer-45003https://curecurrent.com/trials/feasibility-of-intratumoral-washing-fluid-for-detecting-egfr-mutations-in-lung-cancer-45004https://curecurrent.com/trials/symptoms-burden-in-lung-cancer-patients-undergoing-definitive-chemoradiotherapy-insights-from-electronic-patient-reporte-45005https://curecurrent.com/trials/a-study-of-aumolertinib-in-european-participants-with-non-small-cell-lung-cancer-45006https://curecurrent.com/trials/iparomlimab-and-tuvonralimab-combined-with-2-or-4-cycles-of-chemotherapy-as-neoadjuvant-therapy-for-resectable-nsclc-45007https://curecurrent.com/trials/hs-it101-injection-for-advanced-nsclc-45008https://curecurrent.com/trials/efficacy-and-safety-of-anti-pd-1-pd-l1-antibodies-in-combination-with-bevacizumab-and-metronomic-cyclophosphamide-in-pat-45009https://curecurrent.com/trials/a-study-to-examine-biomarkers-from-lung-and-blood-samples-in-participants-with-suspected-lung-cancer-45010https://curecurrent.com/trials/pemetrexed-platinum-with-or-without-bevacizumab-in-brain-metastases-from-patients-with-egfr-alk-negative-non-squamous-no-45011https://curecurrent.com/trials/comparison-of-longer-term-5-year-outcomes-survival-of-smokers-ex-smokers-never-smoker-and-quitters-45012https://curecurrent.com/trials/perioperative-cisgem-rilvegostomig-in-high-risk-resectable-intra-hepatic-cholangiocarcinoma-45013https://curecurrent.com/trials/validation-of-the-spot-mas-lung-test-using-circulating-tumor-dna-for-the-detection-of-lung-cancer-45014https://curecurrent.com/trials/spectalung-screening-patients-with-thoracic-tumors-for-efficient-clinical-trial-access-45015https://curecurrent.com/trials/the-effect-of-esketamine-combined-with-dexmedetomidine-on-postoperative-recovery-quality-in-patients-undergoing-thoracos-45016https://curecurrent.com/trials/prospect-profiling-of-resistance-patterns-oncogenic-signaling-pathways-in-evaluation-of-cancers-of-the-thorax-and-therap-45017https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-mk-3475-with-lenvatinib-e7080-mk-7902-vs-docetaxel-in-participants-with-metastatic-45018https://curecurrent.com/trials/1st-line-durvalumab-in-ps-2-nsclc-patients-45019https://curecurrent.com/trials/prospective-evaluation-of-the-tool-in-lesion-technology-of-the-galaxy-system-in-routine-clinical-practice-45020https://curecurrent.com/trials/resistance-to-the-tyrosine-kinase-inhibitor-osimertinib-and-pharmacokinetics-in-non-small-cell-lung-cancer-45021https://curecurrent.com/trials/pembrolizumab-vibostolimab-coformulation-mk-7684a-or-pembrolizumab-vibostolimab-coformulation-plus-docetaxel-versus-doce-45022https://curecurrent.com/trials/feasibility-of-bronchial-washing-fluid-for-molecular-testing-with-next-generation-sequencing-in-lung-cancer-45023https://curecurrent.com/trials/tovorafenib-day101-or-in-combination-with-pimasertib-for-participants-with-melanoma-and-other-solid-tumors-45024https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-efficacy-of-epacadostat-administered-in-combination-with-nivolumab-in-select-adva-45025https://curecurrent.com/trials/the-watch-the-spot-trial-45026https://curecurrent.com/trials/a-retrospective-cohort-analysis-of-smarca4-deficient-lung-cancer-45027https://curecurrent.com/trials/neoadjuvant-chemotherapy-and-immunotherapy-for-a-selected-group-of-inoperable-pleural-mesothelioma-patients-necim-a-feas-45028https://curecurrent.com/trials/selective-lymph-node-resection-for-invasive-non-small-cell-lung-cancer-with-the-ctr-of-0-5-1-and-the-diameter-of-2-cm-45029https://curecurrent.com/trials/cryoablation-combined-with-lenvatinib-plus-ql1706-iparomlimab-tuvonralimab-in-patients-with-advanced-intrahepatic-cholan-45030https://curecurrent.com/trials/a-perioperative-comprehensive-diagnosis-and-treatment-system-for-lung-cancer-in-the-era-of-neoadjuvant-immunotherapy-45031https://curecurrent.com/trials/covid19-sars-vaccinations-systemic-allergic-reactions-to-sars-cov-2-vaccinations-45032https://curecurrent.com/trials/the-natural-history-and-biological-study-of-pulmonary-recurrent-respiratory-papillomatosis-prrp-45033https://curecurrent.com/trials/a-study-of-gfh925-in-combination-with-cetuximab-in-previously-untreated-advanced-nsclc-harboring-kras-g12c-mutation-45034https://curecurrent.com/trials/inflammation-cachexia-and-therapeutic-response-in-lung-cancer-treated-with-immune-checkpoint-inhibitors-exploratory-obse-45035https://curecurrent.com/trials/quebec-lung-cancer-screening-plus-trial-45036https://curecurrent.com/trials/mr-informed-stereotactic-radiotherapy-for-treatment-of-ultracentral-lung-tumours-utilising-a-dedicated-mr-simulator-for-45037https://curecurrent.com/trials/the-purpose-of-this-study-is-to-evaluate-the-safety-tolerability-and-efficacy-of-tmt101-injection-monotherapy-in-patient-45038https://curecurrent.com/trials/d-0316-versus-icotinib-in-patients-with-locally-advanced-or-metastatic-egfr-sensitising-mutation-positive-nsclc-45039https://curecurrent.com/trials/lung-cancer-screening-in-family-members-and-peers-of-lung-cancer-patients-a-prospective-cohort-study-45040https://curecurrent.com/trials/safety-study-of-enoblituzumab-mga271-in-combination-with-pembrolizumab-or-mga012-in-refractory-cancer-45041https://curecurrent.com/trials/immunocare-rapid-accurate-covid-testing-to-reduce-hospitalization-of-immunocompromised-individuals-45042https://curecurrent.com/trials/efficacy-comparison-of-dostarlimab-plus-chemotherapy-versus-pembrolizumab-plus-chemotherapy-in-participants-with-metasta-45043https://curecurrent.com/trials/survival-efficacy-of-combined-radiotherapy-and-immunotherapy-in-patients-with-metastatic-non-small-cell-lung-carcinoma-45044https://curecurrent.com/trials/bnt162b2-messenger-ribonucleic-acid-mrna-covid-19-vaccine-in-cancer-patients-on-active-treatment-45045https://curecurrent.com/trials/dna-evaluation-of-fragments-for-early-interception-lung-cancer-training-study-delfi-l101-study-45046https://curecurrent.com/trials/development-of-innovative-preclinical-ex-vivo-models-for-the-study-of-sarcomas-and-metastases-from-solid-tumors-45047https://curecurrent.com/trials/datopotamab-deruxtecan-dato-dxd-for-non-small-cell-lung-cancer-nsclc-patients-with-active-brain-metastases-45048https://curecurrent.com/trials/evaluation-of-the-feasibility-and-clinical-relevance-of-liquid-biopsy-in-patients-with-suspicious-metastatic-lung-cancer-45049https://curecurrent.com/trials/press-needle-acupuncture-for-pain-and-quality-of-life-in-lung-cancer-patients-45050https://curecurrent.com/trials/pembrolizumab-plus-bevacizumab-for-treatment-of-brain-metastases-in-metastatic-melanoma-or-non-small-cell-lung-cancer-ns-45051https://curecurrent.com/trials/a-single-center-phase-ii-clinical-trial-evaluating-the-efficacy-of-sacituzumab-tirumotecan-in-combination-with-tagitanli-45052https://curecurrent.com/trials/randomized-trial-of-glutathione-with-anti-pd-1-and-chemotherapy-in-advanced-nsclc-45053https://curecurrent.com/trials/a-clinical-study-of-bt02-in-treating-patients-with-advanced-lung-cancer-45054https://curecurrent.com/trials/perioperative-immunotherapy-for-resectable-limited-stage-sclc-45055https://curecurrent.com/trials/toripalimab-combined-with-chemotherapy-as-adjuvant-therapy-for-non-small-cell-lung-cancer-with-or-without-prior-neoadjuv-45056https://curecurrent.com/trials/aerosolized-sargramostim-added-to-immunotherapy-for-the-treatment-of-patients-with-metastatic-melanoma-to-the-lung-45057https://curecurrent.com/trials/ai-based-deepgem-tool-for-predicting-gene-mutations-in-nsclc-patients-a-randomized-controlled-study-45058https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-efficacy-and-safety-of-hlx26-anti-lag-3-monoclonal-antibody-injection-combined-with-ser-45059https://curecurrent.com/trials/comparison-of-double-lumen-tube-location-verification-techniques-in-single-lung-ventilation-45060https://curecurrent.com/trials/multimodal-large-model-driven-risk-and-prognosis-assessment-for-brain-metastases-in-lung-cancer-45061https://curecurrent.com/trials/organoid-guided-vs-topotecan-therapy-in-relapsed-extensive-stage-small-cell-lung-cancer-45062https://curecurrent.com/trials/ai-models-for-predicting-occult-pleural-dissemination-in-nsclc-45063https://curecurrent.com/trials/a-phase-1-dose-escalation-study-of-zg006-in-patients-with-small-cell-lung-cancer-45064https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-pemigatinib-in-participants-with-relapsed-or-refractory-advanced-non-small-45065https://curecurrent.com/trials/clinical-validation-of-freenome-multiomics-blood-test-for-lung-cancer-screening-45066https://curecurrent.com/trials/a-study-evaluating-concurrent-chemoradiotherapy-combined-with-dual-immune-checkpoint-blockade-for-limited-stage-small-ce-45067https://curecurrent.com/trials/arginase-inhibitor-incb001158-as-a-single-agent-and-in-combination-with-immune-checkpoint-therapy-in-patients-with-advan-45068https://curecurrent.com/trials/sweep-shuttle-walking-test-for-exercise-evaluation-in-pulmonary-resection-45069https://curecurrent.com/trials/observational-prospective-study-of-quality-of-life-in-unresectable-tnm-stage-iii-nsclc-obstinate-45070https://curecurrent.com/trials/a-prospective-multicenter-clinical-study-of-hetrombopag-in-the-prevention-of-thrombocytopenia-caused-by-lung-cancer-ther-45071https://curecurrent.com/trials/to-evaluate-obi-833-obi-821-in-combination-with-first-line-erlotinib-in-patients-with-egfr-mutated-globo-h-positive-loca-45072https://curecurrent.com/trials/study-of-inupadenant-eos100850-with-chemotherapy-as-second-line-treatment-for-nonsquamous-non-small-cell-lung-cancer-45073https://curecurrent.com/trials/a-study-of-real-world-treatment-patterns-and-outcomes-in-chinese-advanced-nsclc-patients-who-previously-received-at-leas-45074https://curecurrent.com/trials/spinal-metastasis-as-the-first-presentation-of-lung-malignancy-clinical-characteristics-and-postoperative-survival-45075https://curecurrent.com/trials/perioperative-study-of-iparomlimab-and-tuvonralimab-in-resectable-nsclc-45076https://curecurrent.com/trials/toripalimab-combined-with-chemotherapy-as-adjuvant-therapy-for-incidental-small-cell-lung-cancer-after-radical-resection-45077https://curecurrent.com/trials/pan-canadian-lung-cancer-observational-study-paleos-45078https://curecurrent.com/trials/prognostic-value-of-sarcopenia-and-nutritional-status-in-early-stage-non-small-cell-lung-cancer-45079https://curecurrent.com/trials/a-clinical-evaluation-of-the-aliya-system-in-late-stage-cancer-45080https://curecurrent.com/trials/feasibility-of-cbct-guided-online-adaptive-radiotherapy-fascinate-45081https://curecurrent.com/trials/the-lung-health-check-pilot-45082https://curecurrent.com/trials/taxoprexin-plus-carboplatin-treatment-for-advanced-lung-cancer-45083https://curecurrent.com/trials/a-study-of-hs-20117-combined-with-aumolertinib-in-participants-with-advanced-non-squamous-non-small-cell-lung-cancer-45084https://curecurrent.com/trials/subcostal-single-port-versus-intercostal-multi-port-robotic-lobectomy-for-non-small-cell-lung-cancer-45085https://curecurrent.com/trials/plasma-metabolomics-as-a-tool-to-distinguish-pet-positive-malignant-from-pet-positive-benign-nodules-45086https://curecurrent.com/trials/sdtm001-injection-as-adjuvant-therapy-for-nsclc-patients-after-radical-surgical-resection-45087https://curecurrent.com/trials/intra-operative-air-leak-management-after-minimally-invasive-lung-segmental-resection-45088https://curecurrent.com/trials/empathy-nsclc-european-registry-for-plasma-based-molecular-profiling-in-advanced-nsclc-patients-45089https://curecurrent.com/trials/pain-control-after-vats-anatomical-pulmonary-resections-45090https://curecurrent.com/trials/intraoperative-blood-pressure-management-and-dexamethasone-in-lung-cancer-surgery-45091https://curecurrent.com/trials/a-study-of-brigatinib-in-participants-with-anaplastic-lymphoma-kinase-positive-alk-advanced-non-small-cell-lung-cancer-n-45092https://curecurrent.com/trials/role-of-mdscs-and-cancer-stem-cells-and-their-cross-talks-in-nsclc-45093https://curecurrent.com/trials/hla-typing-tumor-neoantigen-identification-for-phase-i-ii-study-of-autologous-tcr-t-cells-in-subjects-with-solid-tumors-45094https://curecurrent.com/trials/consolidation-radiotherapy-vs-observation-in-oligoresidual-advanced-non-small-cell-lung-cancer-after-chemo-immunotherapy-45095https://curecurrent.com/trials/phase-i-study-of-autologous-cd8-and-cd4-engineered-t-cell-receptor-t-cells-in-subjects-with-advanced-or-metastatic-solid-45096https://curecurrent.com/trials/long-term-follow-up-study-of-subjects-treated-with-autologous-t-cells-using-the-sleeping-beauty-system-to-express-tcrs-45097https://curecurrent.com/trials/efficacy-and-safety-analysis-of-first-line-abcp-therapy-in-advanced-smarca4-mutated-nsclc-45098https://curecurrent.com/trials/follow-up-of-patients-with-curative-intent-surgical-resection-for-nsclc-45099https://curecurrent.com/trials/camu-camu-prebiotic-and-immune-checkpoint-inhibition-in-patients-with-non-small-cell-lung-cancer-and-melanoma-45100https://curecurrent.com/trials/iadademstat-in-combination-with-paclitaxel-in-relapsed-refractory-sclc-and-extrapulmonary-high-grade-net-45101https://curecurrent.com/trials/role-of-cancer-associated-fibroblast-mdscs-and-immune-cell-interplays-in-the-resistance-of-non-small-cell-lung-cancer-to-45102https://curecurrent.com/trials/a-real-world-study-of-adjuvant-therapy-in-early-stage-nsclc-with-egfr-mutation-positive-in-china-45103https://curecurrent.com/trials/a-study-to-evaluate-pembrolizumab-plus-lenvatinib-in-pd-l1-positive-tki-resistant-nsclc-patients-45104https://curecurrent.com/trials/effect-of-g-csf-on-mdsc-and-cancer-stem-cells-interactions-in-non-small-cell-lung-cancers-circuit-45105https://curecurrent.com/trials/study-of-gt103-in-combination-with-pembrolizumab-in-refractory-metastatic-non-small-cell-lung-cancer-45106https://curecurrent.com/trials/ttx-030-in-combination-with-immunotherapy-and-or-chemotherapy-in-subjects-with-advanced-cancers-45107https://curecurrent.com/trials/principle-test-for-isolation-and-characterization-of-circulating-cancer-cells-ctc-cxcr4-45108https://curecurrent.com/trials/image-navigated-resection-of-lung-nodules-45109https://curecurrent.com/trials/immunotherapy-with-non-ablative-radiation-in-previously-untreated-patients-with-stage-iv-nsclc-45110https://curecurrent.com/trials/nano-crystalline-megestrol-acetate-for-anorexia-cachexia-syndrome-in-advanced-lung-cancer-45111https://curecurrent.com/trials/nab-paclitaxel-with-gemcitabine-for-relapsed-small-cell-cancer-45112https://curecurrent.com/trials/vargado-vargatef-in-2nd-line-therapy-of-non-small-cell-lung-cancer-nsclc-45113https://curecurrent.com/trials/use-of-chinese-herbal-formula-shu-yu-wan-in-lung-cancer-patients-45114https://curecurrent.com/trials/drug-drug-interaction-study-of-tak-788-and-midazolam-in-participants-with-advanced-non-small-cell-lung-cancer-nsclc-45115https://curecurrent.com/trials/phase-ib-ii-study-of-vebreltinib-with-furmonertinib-in-nsclc-patients-with-c-met-amplification-after-egfr-tki-failure-45116https://curecurrent.com/trials/combination-of-concurrent-chemoradiotherapy-with-surufatinib-and-tislelizumab-in-patients-with-locally-advanced-non-smal-45117https://curecurrent.com/trials/electroacupuncture-combined-with-pd-1-inhibitor-for-elderly-patients-with-advanced-nsclc-45118https://curecurrent.com/trials/tislelizumab-combined-with-scrt-in-stage-iiib-c-iv-non-squamous-non-small-cell-lung-cancer-a-prospective-single-arm-phas-45119https://curecurrent.com/trials/phase-i-ii-study-of-plb1004-combined-with-platinum-based-doublet-chemotherapy-in-patients-with-egfr-mutation-positive-45120https://curecurrent.com/trials/perioperative-treatment-of-sunvozertinib-in-stage-ii-iiib-nsclc-45121https://curecurrent.com/trials/acupuncture-for-lung-cancer-related-fatigue-45122https://curecurrent.com/trials/open-label-surufatinib-in-european-patients-with-net-45123https://curecurrent.com/trials/a-phase-ii-randomized-trial-of-neoadjuvant-ivonescimab-or-penpulimab-plus-chemotherapy-in-resectable-nsclc-45124https://curecurrent.com/trials/development-of-clinical-and-biological-database-on-bronchial-cancer-45125https://curecurrent.com/trials/pharmaco-economic-study-of-a-second-line-treatment-in-advanced-non-small-cell-lung-cancer-45126https://curecurrent.com/trials/a-study-of-nivolumab-and-ipilimumab-in-untreated-participants-with-stage-3-non-small-cell-lung-cancer-nsclc-that-is-unab-45127https://curecurrent.com/trials/a-phase-i-study-of-xzp-3621-in-chinese-patients-with-alk-or-ros1-rearrangement-non-small-cell-lung-cancer-45128https://curecurrent.com/trials/lorlatinib-in-ros1-nsclc-with-brain-metastasis-45129https://curecurrent.com/trials/acupuncture-combined-with-pd-1-pd-l1-inhibitors-for-advanced-lung-cancer-45130https://curecurrent.com/trials/a-phase-ii-study-of-ql1706-with-anti-angiogenesis-therapy-and-chemotherapy-in-extensive-stage-small-cell-lung-cancer-45131https://curecurrent.com/trials/neoadjuvant-immunotherapy-plus-chemotherapy-followed-by-concurrent-chemoradiotherapy-and-consolidative-immunotherapy-for-45132https://curecurrent.com/trials/expanded-access-protocol-for-the-use-of-sl-28-in-the-treatment-of-advanced-solid-tumors-45133https://curecurrent.com/trials/pet-ct-based-image-analysis-and-machine-learning-of-hypermetabolic-pulmonary-lesions-45134https://curecurrent.com/trials/x-396-ensartinib-capsules-in-alk-positive-nsclc-patients-with-brain-metastases-45135https://curecurrent.com/trials/a-study-of-bl-b01d1-and-almonertinib-in-patients-with-resectable-egfr-stage-ii-iiib-nsclc-45136https://curecurrent.com/trials/hypofractionated-versus-conventional-chemoradiotherapy-followed-by-consolidative-immunotherapy-in-locally-advanced-nsclc-45137https://curecurrent.com/trials/pembrolizumab-and-chemotherapy-neoadjuvant-adjuvant-of-nsclc-45138https://curecurrent.com/trials/tracking-t-cell-responses-to-evaluate-pembrolizumab-effectiveness-in-advanced-non-small-cell-lung-cancer-45139https://curecurrent.com/trials/a-randomized-controlled-trial-evaluating-the-effectiveness-of-a-novel-risk-stratified-screening-strategy-for-lung-cancer-45140https://curecurrent.com/trials/real-world-study-evaluating-the-long-term-outcomes-of-pegylated-interferon-2b-treatment-in-the-families-with-clusters-of-45141https://curecurrent.com/trials/real-world-study-of-taletrectinib-for-advanced-ros1-nsclc-with-brain-metastases-45142https://curecurrent.com/trials/pemetrexed-and-carboplatin-with-or-without-anlotinib-hydrochloride-for-osimertinib-resistant-non-squamous-nsclc-45143https://curecurrent.com/trials/a-study-on-exploring-the-abscopal-effect-induced-by-different-radioimmunotherapy-combination-patterns-in-the-treatment-o-45144https://curecurrent.com/trials/a-study-of-bms-986466-with-adagrasib-with-or-without-cetuximab-in-participants-with-kirsten-rat-sarcoma-virus-glycine-12-45145https://curecurrent.com/trials/a-study-in-patients-with-braf-v600e-mutant-metastatic-non-small-cell-lung-cancer-octopus-45146https://curecurrent.com/trials/prophylactic-proton-pump-inhibition-for-esophageal-protection-in-lung-radiation-therapy-45147https://curecurrent.com/trials/standard-of-care-systemic-therapy-with-or-without-local-therapy-in-patients-with-oligoprogressive-non-small-cell-lung-ca-45148https://curecurrent.com/trials/a-phase-ii-iii-study-of-ibb0979-in-combination-with-topotecan-versus-topotecan-in-relapsed-small-cell-lung-cancer-45149https://curecurrent.com/trials/ipilimumab-and-nivolumab-in-recurrent-extensive-stage-small-cell-lung-cancer-after-receiving-platinum-based-chemotherapy-45150https://curecurrent.com/trials/vaccination-of-advanced-stage-lung-cancer-patients-45151https://curecurrent.com/trials/streamlining-radioembolization-for-intrahepatic-cholangiocarcinoma-45152https://curecurrent.com/trials/transthoracic-vs-transbronchial-cryoablation-for-early-stage-peripheral-lung-cancer-45153https://curecurrent.com/trials/transbronchial-mwa-for-pulmonary-tumors-45154https://curecurrent.com/trials/specimen-and-clinical-data-collection-plan-for-ldct-screening-participants-45155https://curecurrent.com/trials/deb-bace-for-primary-lung-cancer-a-retrospective-single-arm-multicenter-study-on-efficacy-and-safety-45156https://curecurrent.com/trials/afatinib-combined-with-chemotherapy-as-conversion-therapy-in-unresectable-egfr-sensitive-mutation-positive-stage-iii-nsc-45157https://curecurrent.com/trials/effect-of-mobile-augmented-reality-counseling-on-improving-shared-decision-making-in-thoracic-surgery-45158https://curecurrent.com/trials/on-treatment-biomarkers-in-metastatic-colorectal-cancer-for-life-45159https://curecurrent.com/trials/naloxegol-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-45160https://curecurrent.com/trials/mediastinal-ebus-cryobiopsy-study-in-sweden-45161https://curecurrent.com/trials/small-extracellular-vesicle-mirnas-as-predictive-biomarkers-for-immunochemotherapy-efficacy-in-extensive-stage-small-cel-45162https://curecurrent.com/trials/analysis-of-circulating-tumor-dna-dynamics-to-predict-and-monitor-response-to-tki-in-patients-with-advanced-nsclc-45163https://curecurrent.com/trials/srs-srt-hypo-rt-versus-ha-wbrt-for-no-more-than-10-brain-metastases-in-sclc-45164https://curecurrent.com/trials/a-phase-study-of-rc108-in-combination-with-furmonertinib-for-the-first-line-treatment-of-egfr-mutated-combined-met-posit-45165https://curecurrent.com/trials/study-of-an-early-change-of-a-chemotherapeutic-doublet-versus-four-cycles-of-chemotherapy-in-advanced-non-small-cell-lun-45166https://curecurrent.com/trials/a-study-on-the-first-line-treatment-of-small-cell-lung-cancer-with-adebrelimab-and-vunakizumab-and-chemotherapy-45167https://curecurrent.com/trials/combination-chemotherapy-with-or-without-surgery-chemoradiotherapy-in-patients-with-malignant-pleural-mesothelioma-45168https://curecurrent.com/trials/epione-guided-lung-evaluation-45169https://curecurrent.com/trials/tislelizumab-combined-with-recombinant-human-endostatin-combined-with-chemotherapy-for-unresectable-stage-iii-non-small-45170https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-incb099280-in-participants-with-advanced-solid-tumors-45171https://curecurrent.com/trials/efficacy-and-safety-of-super-hyperfractionation-pulse-radiotherapy-combined-with-icis-for-advanced-nsclc-45172https://curecurrent.com/trials/a-prospective-phase-ii-study-of-postoperative-concurrent-chemoradiotherapy-in-patients-with-intrahepatic-cholangiocarcin-45173https://curecurrent.com/trials/an-observational-clinical-study-of-stereotactic-radiotherapy-for-advanced-non-small-cell-lung-cancer-with-stable-disease-45174https://curecurrent.com/trials/phase-1-study-of-hs-20093-combinations-in-patients-with-extensive-stage-small-cell-lung-cancer-45175https://curecurrent.com/trials/lung-cancer-screening-of-family-members-of-patients-with-mutation-driven-lung-cancer-45176https://curecurrent.com/trials/study-on-the-optimal-combination-pattern-of-the-combined-treatment-of-radiotherapy-and-immunotherapy-for-the-abscopal-ef-45177https://curecurrent.com/trials/phase-i-study-of-jyp0322-in-ros1-fusion-positive-solid-tumors-45178https://curecurrent.com/trials/omitting-clinical-target-volume-in-radical-treatment-of-unresectable-stage-iii-non-small-cell-lung-cancer-45179https://curecurrent.com/trials/ramucirumab-and-pembrolizumab-for-the-treatment-of-egfr-mutant-recurrent-or-metastatic-non-small-cell-lung-cancer-45180https://curecurrent.com/trials/relationship-of-nutritional-status-to-chemotherapy-treatment-completion-and-outcomes-in-cancer-patients-45181https://curecurrent.com/trials/predicting-immunotherapy-response-and-survival-of-lung-cancer-patients-using-artificial-intelligence-and-radiomics-radio-45182https://curecurrent.com/trials/the-effect-of-semi-recumbent-position-on-hypoxemia-after-lung-segment-lobe-surgery-45183https://curecurrent.com/trials/prognostic-value-of-mir-21-and-mir-486-in-pulmonary-nodule-surgery-45184https://curecurrent.com/trials/intratumoral-gene-mediated-cytotoxic-immunotherapy-in-patients-with-resectable-non-small-cell-lung-cancer-45185https://curecurrent.com/trials/study-of-front-line-pembrolizumab-and-valemetostat-in-pd-l1-positive-hpv-negative-recurrent-metastatic-squamous-cell-car-45186https://curecurrent.com/trials/89zr-girentuximab-for-pet-imaging-of-caix-positive-solid-tumors-45187https://curecurrent.com/trials/personalized-dc-vaccines-in-non-small-cell-lung-cancer-45188https://curecurrent.com/trials/radiation-therapy-followed-by-tislelizumab-and-anlotinib-aeoadjuvant-adjuvant-therapy-for-stage-ii-iiia-nsclc-45189https://curecurrent.com/trials/hybrid-apc-therapy-in-early-central-lung-neoplasms-45190https://curecurrent.com/trials/phase-i-study-of-bc008-1a-injection-in-patients-with-advanced-solid-tumors-45191https://curecurrent.com/trials/study-of-atezolizumab-in-advanced-non-oncogene-addicted-nsclc-with-pd-l1-50-including-longitudinal-c-flip-assessment-in-45192https://curecurrent.com/trials/a-clinical-trial-of-tg6050-in-patients-with-metastatic-non-small-cell-lung-cancer-delivir-45193https://curecurrent.com/trials/robotic-assisted-navigation-for-lung-nodule-localization-a-non-inferiority-study-45194https://curecurrent.com/trials/a-multi-tumor-open-phase-i-clinical-study-on-the-progression-of-first-line-anti-tumor-therapy-using-cardonizumab-combine-45195https://curecurrent.com/trials/multiple-omics-sequencing-technologies-in-predicting-the-efficacy-and-monitoring-the-recurrence-of-non-small-cell-lung-c-45196https://curecurrent.com/trials/research-on-new-diagnosis-and-treatment-technologies-for-early-lung-cancer-45197https://curecurrent.com/trials/dacomitinib-plus-pd-0325901-in-advanced-kras-mutant-nsclc-45198https://curecurrent.com/trials/single-nucleotide-polymorphism-snp-study-icorg-08-40-v4-45199https://curecurrent.com/trials/efficacy-of-argon-helium-cryoablation-plus-pd-1-inhibitors-in-nsclc-45200https://curecurrent.com/trials/a-safety-study-of-212pb-pentixather-radioligand-therapy-45201https://curecurrent.com/trials/a-retrospective-real-world-study-on-the-efficacy-and-safety-of-anlotinib-hydrochloride-combined-with-immunotherapy-maint-45202https://curecurrent.com/trials/tumor-associated-neutrophils-as-a-biomarker-of-chemo-immunotherapy-response-in-locally-advanced-non-small-cell-lung-canc-45203https://curecurrent.com/trials/pembrolizumab-vibostolimab-mk-7684a-or-atezolizumab-in-combination-with-chemotherapy-in-first-line-treatment-of-extensiv-45204https://curecurrent.com/trials/lapatinib-plus-trametinib-in-kras-mutant-nsclc-45205https://curecurrent.com/trials/clinical-evaluation-of-the-lung-cancer-ai-based-decision-support-tool-in-low-dose-lung-ct-45206https://curecurrent.com/trials/intercostal-cryoanalgesia-for-chronic-pain-after-vats-lung-resection-45207https://curecurrent.com/trials/elderly-with-locally-advanced-lung-cancer-deciding-through-geriatric-assessment-on-the-optimal-treatment-strategy-45208https://curecurrent.com/trials/the-neuroendocrine-effects-of-pioglitazone-in-patients-with-cancer-and-cachexia-45209https://curecurrent.com/trials/intercostal-cryoanalgesia-for-acute-pain-after-vats-lung-resection-45210https://curecurrent.com/trials/phase-ii-study-of-shr-1210-anti-pd-1-antibody-combination-with-apatinib-versus-pemetrexed-and-carboplatin-in-subjects-wi-45211https://curecurrent.com/trials/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-small-cell-lung-cancer-nsclc-sub-s-45212https://curecurrent.com/trials/rapid-absorbance-based-detection-of-inner-cheek-cell-abnormalities-using-light-spectroscopy-for-risk-evaluation-of-lung-45213https://curecurrent.com/trials/the-diagnostic-accuracy-and-clinical-value-of-fapi-pet-in-pleural-mesothelioma-45214https://curecurrent.com/trials/medical-access-program-for-datopotamab-deruxtecan-in-egfrm-nsclc-patients-45215https://curecurrent.com/trials/goal-directed-fluid-therapy-for-thoracoscopic-lobectomy-45216https://curecurrent.com/trials/evidence-based-nursing-for-psychological-resilience-in-lung-cancer-chemotherapy-patients-45217https://curecurrent.com/trials/study-of-intravenous-iv-abbv-637-alone-or-in-combination-with-iv-docetaxel-osimertinib-to-assess-adverse-events-and-chan-45218https://curecurrent.com/trials/low-dose-nivolumab-with-chemotherapy-vs-standard-chemotherapy-as-first-line-treatment-in-advanced-or-metastatic-nsclc-45219https://curecurrent.com/trials/evidence-based-nursing-for-fatigue-and-quality-of-life-in-lung-cancer-chemotherapy-45220https://curecurrent.com/trials/cisplatin-carboplatin-and-etoposide-with-or-without-nivolumab-in-treating-patients-with-extensive-stage-small-cell-lung-45221https://curecurrent.com/trials/microbiota-transplant-to-cancer-patients-who-have-failed-immunotherapy-using-faeces-from-clinical-responders-45222https://curecurrent.com/trials/fih-trial-of-vert-002-in-patients-with-locally-advanced-or-metastatic-solid-tumors-with-met-alterations-45223https://curecurrent.com/trials/multi-omics-detection-techniques-for-differentiating-benign-and-malignant-pulmonary-nodules-45224https://curecurrent.com/trials/vinorelbine-in-treating-patients-with-advanced-solid-tumors-that-have-not-responded-to-treatment-and-liver-dysfunction-45225https://curecurrent.com/trials/ttx-030-single-agent-and-in-combination-with-immunotherapy-or-chemotherapy-for-patients-with-advanced-cancers-45226https://curecurrent.com/trials/18f-f-arag-total-body-pet-imaging-and-healthy-subjects-and-lung-cancer-patients-45227https://curecurrent.com/trials/prostep-a-feasibility-trial-using-pros-and-step-data-to-monitor-patients-with-lung-and-gi-cancers-45228https://curecurrent.com/trials/clinical-safty-and-efficacy-study-of-infusion-of-inkt-cells-and-cd8-t-cells-in-patients-with-advanced-solid-tumor-45229https://curecurrent.com/trials/pank-003-cell-injection-combined-with-standard-adjuvant-chemotherapy-after-surgery-in-patients-with-stage-iiia-nsclc-45230https://curecurrent.com/trials/a-phase-ib-study-of-jmkx001899-in-combination-with-other-therapies-in-advanced-nsclc-harboring-kras-g12c-mutation-45231https://curecurrent.com/trials/assessment-the-effectiveness-of-btva-in-copd-and-ablation-in-pulmonary-nodules-by-pulmonary-mri-45232https://curecurrent.com/trials/primary-resistance-mechanisms-of-alk-tkis-45233https://curecurrent.com/trials/a-multicenter-study-in-bronchoscopy-combining-stimulated-raman-histology-with-artificial-intelligence-for-rapid-lung-can-45234https://curecurrent.com/trials/a-study-to-investigate-lyl845-in-adults-with-solid-tumors-45235https://curecurrent.com/trials/effect-of-bilateral-vs-unilateral-alveolar-recruitment-on-gas-exchange-in-lung-resection-45236https://curecurrent.com/trials/effects-of-different-preoperative-oral-rehydration-protocols-in-undergoing-thoracoscopic-radical-lung-cancer-surgery-45237https://curecurrent.com/trials/a-confirmatory-clinical-study-in-nsclc-patients-with-met-exon-14-mutation-kunpeng-2-45238https://curecurrent.com/trials/prospective-multicenter-cohort-study-for-the-development-and-evaluation-of-risk-stratification-tools-for-lung-cancers-an-45239https://curecurrent.com/trials/a-clinical-study-of-si-b001-combined-with-docetaxel-in-the-treatment-of-non-small-cell-lung-adenocarcinoma-and-lung-squa-45240https://curecurrent.com/trials/exercise-and-nutrition-on-early-stage-nsclc-outcomes-the-starlight-study-45241https://curecurrent.com/trials/a-study-of-fluzoparib-shr-3162-and-temozolomide-with-or-without-shr-1316-in-treating-patients-with-replapsed-small-cell-45242https://curecurrent.com/trials/tislelizumab-in-combination-with-sitravatinib-in-participants-with-locally-advanced-or-metastatic-non-small-cell-lung-ca-45243https://curecurrent.com/trials/risk-and-prognosis-of-brain-metastasis-in-non-small-cell-lung-cancer-45244https://curecurrent.com/trials/a-prospective-single-arm-phase-ii-clinical-study-of-tislelizumab-combined-with-anlotinib-and-platinum-based-doublet-peri-45245https://curecurrent.com/trials/apl-101-study-of-subjects-with-nsclc-with-c-met-exon-14-skip-mutations-and-c-met-dysregulation-advanced-solid-tumors-45246https://curecurrent.com/trials/clinical-outcomes-of-tislelizumab-combined-with-chemotherapy-as-induction-therapy-in-stage-iii-ctnm-iiib-iiic-nsclc-45247https://curecurrent.com/trials/a-nutritional-supplement-to-support-people-with-non-small-cell-lung-cancer-45248https://curecurrent.com/trials/oral-metronomic-vinorelbine-and-pd-1-inhibitors-in-elderly-non-small-cell-lung-cancer-45249https://curecurrent.com/trials/the-impact-of-ai-assistance-on-radiologist-performance-and-healthcare-costs-in-ldct-based-lung-cancer-screening-45250https://curecurrent.com/trials/a-multicenter-phase-ii-randomized-trial-of-limertinib-followed-by-sintilimab-and-chemotherapy-vs-limertinib-followed-by-45251https://curecurrent.com/trials/outpatient-pulmonary-rehabilitation-in-non-small-cell-lung-cancer-receiving-immunotherapy-45252https://curecurrent.com/trials/radiotherapy-or-observation-of-liver-metastases-in-small-cell-lung-cancer-45253https://curecurrent.com/trials/neoadjuvant-sugemalimab-chemotherapy-followed-by-adjuvant-sugemalimab-for-patients-with-resectable-stage-ii-iiia-non-sma-45254https://curecurrent.com/trials/early-palliative-care-in-patients-with-advanced-lung-cancer-using-an-e-health-ecosystem-45255https://curecurrent.com/trials/neoadjuvant-and-adjuvant-therapy-studies-of-sindilizumab-in-resectable-lung-cancer-45256https://curecurrent.com/trials/similar-efficacy-safety-and-immunogenicity-of-fyb206-in-comparison-to-keytruda-as-add-on-to-chemotherapy-in-patients-wit-45257https://curecurrent.com/trials/feasibility-of-an-early-palliative-care-intervention-for-metastatic-cancer-patients-a-phase-2-study-45258https://curecurrent.com/trials/cx3cr1-t-cell-predict-immunotherapy-efficacy-45259https://curecurrent.com/trials/maintenance-pembrolizumab-at-usual-or-low-dose-in-non-squamous-lung-cancer-a-non-inferiority-study-45260https://curecurrent.com/trials/adebrelimab-chemotherapy-as-neoadjuvant-therapy-for-resectable-nsclc-45261https://curecurrent.com/trials/enteral-nutrition-with-l-carnitine-for-cachexia-in-non-small-cell-lung-cancer-45262https://curecurrent.com/trials/interstitial-pneumonitis-associated-with-egfr-tki-and-combined-with-pd-1-pd-l1-45263https://curecurrent.com/trials/digital-outreach-intervention-for-lung-cancer-screening-45264https://curecurrent.com/trials/xentuzumab-bi-836845-plus-afatinib-in-patients-with-epidermal-growth-factor-receptor-egfr-mutant-non-small-cell-lung-can-45265https://curecurrent.com/trials/efficacy-and-safety-of-chemoimmunotherapy-and-carbon-ion-radiotherapy-in-unresectable-locally-advanced-non-small-cell-lu-45266https://curecurrent.com/trials/diagnosis-of-multiple-cancer-and-monitoring-of-minimal-residual-tumors-after-treatment-using-blood-and-high-sensitivity-45267https://curecurrent.com/trials/evaluation-of-a-new-open-source-virtual-bronchoscope-navigation-system-45268https://curecurrent.com/trials/poly-iclc-hiltonol-vaccine-in-malignant-pleural-mesothelioma-45269https://curecurrent.com/trials/a-first-in-human-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ds-6051b-45270https://curecurrent.com/trials/pembrolizumab-and-olaparib-treatment-of-extensive-small-cell-lung-cancer-es-sclc-45271https://curecurrent.com/trials/ssgj-707-in-advanced-non-small-cell-lung-cancer-45272https://curecurrent.com/trials/a-study-evaluating-the-efficacy-of-pd-1-inhibitor-combined-with-denosumab-and-chemotherapy-in-locally-advanced-or-metast-45273https://curecurrent.com/trials/nintedanib-in-molecularly-selected-patients-with-advanced-non-small-cell-lung-cancer-45274https://curecurrent.com/trials/active-cycle-of-breathing-techniques-on-respiratory-distress-symptom-cluster-45275https://curecurrent.com/trials/real-world-durvalumab-in-extensive-stage-small-cell-lung-cancer-45276https://curecurrent.com/trials/electroacupuncture-combined-with-immune-checkpoint-inhibitors-as-adjuvant-therapy-after-surgery-for-early-stage-non-smal-45277https://curecurrent.com/trials/her3-dxd-patritumab-deruxtecan-u3-1402-in-combination-with-osimertinib-in-subjects-with-locally-advanced-or-metastatic-e-45278https://curecurrent.com/trials/complication-and-lung-function-impairment-prediction-using-perfusion-and-ct-air-trapping-45279https://curecurrent.com/trials/study-to-compare-furmonertinib-to-platinum-based-chemotherapy-for-patients-with-locally-advanced-or-metastatic-non-small-45280https://curecurrent.com/trials/walking-for-recovery-from-surgery-in-improving-quality-of-life-in-older-adults-with-lung-or-gastrointestinal-cancer-and-45281https://curecurrent.com/trials/a-single-arm-multicenter-prospective-clinical-study-of-adebrelimab-combined-with-apatinib-neoadjuvant-therapy-for-resect-45282https://curecurrent.com/trials/prophylaxis-for-patients-at-risk-of-covid-19-infection-v-45283https://curecurrent.com/trials/radical-resection-with-contralateral-lymph-node-dissection-for-clinical-n3-nsclc-45284https://curecurrent.com/trials/dzd9008-in-combination-with-bevacizumab-in-locally-advanced-or-metastatic-nsclc-patients-with-egfr-mutation-wu-kong29-45285https://curecurrent.com/trials/international-registry-of-congenital-portosystemic-shunt-ircpss-45286https://curecurrent.com/trials/first-line-treatment-of-participants-with-stage-iv-squamous-non-small-cell-lung-cancer-with-necitumumab-and-gemcitabine-45287https://curecurrent.com/trials/a-multi-omics-sequencing-based-model-for-predicting-efficacy-and-dynamic-monitoring-of-treatment-in-small-cell-lung-canc-45288https://curecurrent.com/trials/a-study-of-mhb088c-injection-versus-treatment-of-physician-s-choice-in-subjects-with-relapsed-small-cell-lung-cancer-45289https://curecurrent.com/trials/clinical-application-study-of-pet-ct-for-differential-diagnosis-of-non-small-cell-lung-cancer-45290https://curecurrent.com/trials/phase-ib-first-in-human-dose-escalation-of-gt103-in-refractory-advanced-stage-non-small-cell-lung-cancer-top-1902-45291https://curecurrent.com/trials/randomized-study-of-carbon-ion-boost-in-hypoxic-lesions-for-locally-advanced-non-small-cell-lung-cancer-45292https://curecurrent.com/trials/spatial-fragmentation-combined-with-low-dose-radiotherapy-for-immunotherapy-combined-with-chemotherapy-resistant-locally-45293https://curecurrent.com/trials/tubeless-anesthesia-in-preventing-lung-complications-in-patients-undergoing-surgery-for-early-stage-lung-cancer-45294https://curecurrent.com/trials/postoperative-telerehabilitation-in-older-adults-45295https://curecurrent.com/trials/long-term-outcomes-among-patients-with-programmed-death-ligand-1-1-metastatic-non-small-cell-lung-cancer-treated-with-fi-45296https://curecurrent.com/trials/switch-maintenance-pembrolizumab-in-patients-with-nsclc-after-first-line-platinum-doublet-chemotherapy-45297https://curecurrent.com/trials/feasibility-study-of-tissue-and-blood-collection-in-oncogene-addicted-and-neoadjuvantly-treated-non-small-cell-lung-canc-45298https://curecurrent.com/trials/ga-dpa-in-the-lung-cancer-diagnosis-45299https://curecurrent.com/trials/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-small-cell-lung-cancer-nsclc-45300https://curecurrent.com/trials/a-study-of-cdx-585-in-patients-with-advanced-malignancies-45301https://curecurrent.com/trials/sintilimab-plus-anlotinib-as-second-or-further-line-therapy-for-es-sclc-who-have-progressed-after-anti-pd-1-l1-therapy-45302https://curecurrent.com/trials/reducing-chronic-breathlessness-in-adults-by-following-a-self-guided-internet-based-supportive-intervention-self-breathe-45303https://curecurrent.com/trials/immunotherapy-with-or-without-sbrt-in-patients-with-stage-iv-non-small-cell-lung-cancer-45304https://curecurrent.com/trials/carbon-ion-therapy-for-peripheral-non-small-cell-lung-cancer-45305https://curecurrent.com/trials/pre-approval-access-with-amivantamab-jnj-61186372-in-participants-with-metastatic-non-small-cell-lung-cancer-45306https://curecurrent.com/trials/national-project-on-vaccines-covid-19-and-frail-patients-45307https://curecurrent.com/trials/improving-pharmacological-transition-of-palliative-care-patients-from-inpatient-to-outpatient-care-45308https://curecurrent.com/trials/carbon-ion-radiotherapy-for-locally-advanced-lung-cancer-in-elderly-patients-45309https://curecurrent.com/trials/testing-the-effects-of-mk-3475-pembrolizumab-with-or-without-the-usual-chemotherapy-treatment-for-patients-70-years-of-a-45310https://curecurrent.com/trials/dose-escalated-adaptive-radiotherapy-of-thoracic-disease-for-small-cell-lung-cancer-45311https://curecurrent.com/trials/hypofractionated-boost-before-chemoradiation-for-patients-with-stage-ii-iii-non-small-cell-lung-cancer-unsuitable-for-su-45312https://curecurrent.com/trials/effect-of-rapid-rollover-on-pneumothorax-after-ct-guided-lung-biopsy-45313https://curecurrent.com/trials/phase-2-study-of-dacomitinib-in-nsclc-45314https://curecurrent.com/trials/a-pan-asian-clinical-database-of-egfr-exon-20-insertion-mutated-nsclc-45315https://curecurrent.com/trials/neoadjuvant-wx-0593-in-resectable-alk-positive-or-ros1-positive-non-small-cell-lung-cancer-45316https://curecurrent.com/trials/sbrt-followed-by-neoadjuvant-immunochemotherapy-in-resectable-stage-ii-to-iii-non-small-cell-lung-cancer-45317https://curecurrent.com/trials/d-bace-in-combination-with-chemotherapy-and-carelizumab-for-resectable-ii-iiia-or-potentially-resectable-t3-4n2-stage-ii-45318https://curecurrent.com/trials/pulmonary-resection-and-intensive-rehabilitation-45319https://curecurrent.com/trials/study-of-lorlatinib-in-people-with-alk-positive-non-small-cell-lung-cancer-45320https://curecurrent.com/trials/pei-regimen-a-therapeutic-option-in-small-cell-lung-cancer-a-monoinstitutional-experience-of-46-consecutive-cases-45321https://curecurrent.com/trials/rarecells-molecular-biomarkers-for-early-detection-of-lung-cancer-45322https://curecurrent.com/trials/phase-2-dacomitinib-study-on-patients-with-egfr-driven-advanced-solid-tumours-with-low-egfr-as1-incrna-expr-or-other-nov-45323https://curecurrent.com/trials/toward-high-fidelity-adaptive-radiotherapy-in-the-thorax-45324https://curecurrent.com/trials/a-study-of-neoadjuvant-adjuvant-durvalumab-for-the-treatment-of-patients-with-resectable-non-small-cell-lung-cancer-45325https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-ql2107-plus-chemo-and-compare-with-keytruda-in-participants-with-iv-nqnsclc-45326https://curecurrent.com/trials/dna-methylation-biomarkers-to-predict-survival-after-surgery-for-lung-adenocarcinoma-45327https://curecurrent.com/trials/pd-1-combined-with-bevacizumab-and-pcsk-9-inhibitor-in-patients-with-advanced-nsclc-who-have-progressed-after-anti-pd-1-45328https://curecurrent.com/trials/a-study-of-egf816-and-gefitinib-in-tki-na-ve-egfr-mutant-non-small-cell-lung-cancer-45329https://curecurrent.com/trials/validation-of-a-multi-gene-test-for-lung-cancer-risk-45330https://curecurrent.com/trials/postoperative-egfr-tki-therapy-forcontralateral-pulmonary-nodules-in-patients-with-egfr-mutant-nsclc-armor2501-45331https://curecurrent.com/trials/ai-driven-precision-diagnostic-system-for-lung-cancer-based-on-liquid-biopsy-45332https://curecurrent.com/trials/efficacy-and-biomarkers-of-the-second-line-treatment-of-adebelizumab-combined-with-irinotecan-liposome-in-advanced-small-45333https://curecurrent.com/trials/the-safety-and-feasibility-of-costal-bone-marrow-aspiration-during-thoracic-surgery-45334https://curecurrent.com/trials/trilaciclib-in-combination-with-docetaxel-for-second-line-and-beyond-treatment-of-locally-advanced-or-metastatic-nsclc-45335https://curecurrent.com/trials/medical-access-program-for-patritumab-deruxtecan-45336https://curecurrent.com/trials/phase-ii-study-of-platinum-cisplatin-carboplatin-and-polymeric-micelles-paclitaxel-pm-pac-with-ivonescimab-in-first-line-45337https://curecurrent.com/trials/comparison-of-spect-ct-perfusion-and-volumetric-ct-volume-45338https://curecurrent.com/trials/tusamitamab-ravtansine-sar408701-in-combination-with-ramucirumab-or-ramucirumab-and-pembrolizumab-in-pretreated-patients-45339https://curecurrent.com/trials/omitting-ctv-for-primary-tumor-in-ls-sclc-45340https://curecurrent.com/trials/two-schedules-of-hyperfractionated-thoracic-radiotherapy-in-limited-disease-small-cell-lung-cancer-45341https://curecurrent.com/trials/phase-1-2-study-of-bbt-176-in-advanced-nsclc-with-progression-after-egfr-tki-treatment-45342https://curecurrent.com/trials/engineering-evaluation-of-the-helix-ventilator-45343https://curecurrent.com/trials/a-study-on-the-efficacy-and-safety-of-golidocitinib-combined-with-tislelizumab-and-chemotherapy-as-first-line-treatment-45344https://curecurrent.com/trials/pembrolizumab-after-radiation-therapy-and-chemotherapy-in-limited-stage-small-cell-lung-cancer-45345https://curecurrent.com/trials/a-pilot-study-to-explore-the-role-of-gut-flora-in-metastatic-mesothelioma-45346https://curecurrent.com/trials/interventional-ablation-for-early-stage-lung-cancer-45347https://curecurrent.com/trials/factors-determine-the-feasibility-and-surgical-margin-quality-of-sublobar-resection-for-non-small-cell-lung-cancer-45348https://curecurrent.com/trials/ai-based-ultrasound-prediction-model-for-intracranial-pressure-and-prognosis-in-lung-cancer-patients-with-leptomeningeal-45349https://curecurrent.com/trials/complementary-treatment-of-pg2-to-improve-clinical-benefit-response-and-quality-of-life-in-fatigue-45350https://curecurrent.com/trials/tunisian-lung-cancer-study-45351https://curecurrent.com/trials/comparison-of-continuous-esp-versus-tea-after-thoracotomy-45352https://curecurrent.com/trials/comparison-paravertebral-and-serratus-anterior-plane-block-in-video-assisted-thoracoscopic-surgery-45353https://curecurrent.com/trials/lurbinectedin-pm01183-combined-with-pembrolizumab-in-small-cell-lung-cancer-45354https://curecurrent.com/trials/platform-trial-of-novel-regimens-versus-standard-of-care-soc-in-participants-with-non-small-cell-lung-cancer-nsclc-sub-s-45355https://curecurrent.com/trials/clinical-study-on-chimeric-antigen-receptor-t-lymphocyte-car-t-targeting-cea-for-the-treatment-of-cea-positive-advanced-45356https://curecurrent.com/trials/ak129-combination-therapy-for-advanced-solid-tumors-45357https://curecurrent.com/trials/real-world-utilization-and-outcomes-with-dacomitinib-first-line-treatment-for-egfr-mutation-positive-advanced-non-small-45358https://curecurrent.com/trials/a-trial-to-compare-the-efficacy-safety-pharmacokinetics-and-immunogenicity-of-hd204-to-avastin-in-advanced-non-squamous-45359https://curecurrent.com/trials/first-line-sintilimab-combined-with-anlotinib-and-platinum-doublet-chemotherapy-in-malignant-pleural-mesothelioma-45360https://curecurrent.com/trials/neoadjuvant-durvalumab-and-chemotherapy-followed-by-surgery-crt-and-durvalumab-in-borderline-resectable-stage-iii-nsclc-45361https://curecurrent.com/trials/lung-cancer-screening-eligibility-assessment-45362https://curecurrent.com/trials/phase-1-2-study-of-the-highly-selective-ret-inhibitor-pralsetinib-blu-667-in-participants-with-thyroid-cancer-non-small-45363https://curecurrent.com/trials/early-intervention-strategies-for-lung-cancer-45364https://curecurrent.com/trials/pembrolizumab-plus-chemotherapy-in-nsclc-with-targetable-genetic-alterations-after-progression-on-targeted-agents-45365https://curecurrent.com/trials/ds-8201a-in-human-epidermal-growth-factor-receptor-2-her2-expressing-or-mutated-non-small-cell-lung-cancer-45366https://curecurrent.com/trials/liquid-biopsy-lung-and-colon-cancer-in-andalucia-45367https://curecurrent.com/trials/the-effect-of-pranayama-breathing-exercise-on-quality-of-life-in-lung-cancer-patients-45368https://curecurrent.com/trials/stereotactic-body-radiotherapy-followed-by-tislelizumab-plus-platinum-based-chemotherapy-versus-tislelizumab-plus-platin-45369https://curecurrent.com/trials/evaluating-safety-and-biomarkers-using-dk210-egfr-for-locally-advanced-or-metastatic-egfr-tumors-45370https://curecurrent.com/trials/rta-408-in-the-treatment-of-advanced-solid-tumors-nsclc-melanoma-discover-45371https://curecurrent.com/trials/safety-immunogenicity-and-preliminary-clinical-activity-study-of-pdc-lung01-cancer-vaccine-in-nsclc-45372https://curecurrent.com/trials/study-of-ngm120-in-subjects-with-advanced-solid-tumors-pancreatic-cancer-and-prostate-cancer-using-combination-therapy-45373https://curecurrent.com/trials/physical-activity-during-chemo-and-or-immunotherapy-for-lung-cancer-45374https://curecurrent.com/trials/pd-l1-inhibitor-combined-with-apatinib-as-first-line-maintenance-treatment-for-extensive-stage-small-cell-lung-cancer-45375https://curecurrent.com/trials/study-of-pf-06940434-in-patients-with-advanced-or-metastatic-solid-tumors-45376https://curecurrent.com/trials/chemoradiation-followed-by-durvalumab-in-poor-risk-and-or-elderly-patients-with-stage-iii-nsclc-45377https://curecurrent.com/trials/targeted-anti-cea-car-t-immunotherapy-for-advanced-lung-cancer-45378https://curecurrent.com/trials/a-study-of-imm-6-415-in-ras-raf-mutant-solid-tumors-45379https://curecurrent.com/trials/tocilizumab-for-prevention-of-respiratory-failure-in-patients-with-severe-covid-19-infection-45380https://curecurrent.com/trials/nivolumab-and-ipilimumab-in-combination-with-immunogenic-chemotherapy-for-patients-with-advanced-nsclc-45381https://curecurrent.com/trials/improving-patient-reported-outcomes-after-lung-cancer-surgery-with-mobile-internet-platform-45382https://curecurrent.com/trials/cemiplimab-for-the-treatment-of-untreated-brain-metastases-from-pd-l1-50-non-small-cell-lung-cancer-45383https://curecurrent.com/trials/safety-pharmacokinetics-and-preliminary-efficacy-of-cs231295-in-advanced-solid-tumors-45384https://curecurrent.com/trials/risk-stratification-for-patients-with-hospital-diagnosed-advanced-lung-cancer-45385https://curecurrent.com/trials/a-digital-therapeutic-solution-for-cancer-patients-45386https://curecurrent.com/trials/prophet-study-ctdna-guided-personalized-induction-immunochemotherapy-for-nsclc-45387https://curecurrent.com/trials/gene-molecular-alterations-as-disease-prognostic-markers-in-patients-with-non-small-cell-lung-cancer-nsclc-45388https://curecurrent.com/trials/a-culturally-based-palliative-care-tele-consult-program-for-rural-southern-elders-45389https://curecurrent.com/trials/study-of-durvalumab-in-combination-with-platinum-and-etoposide-for-the-first-line-treatment-of-patients-with-extensive-s-45390https://curecurrent.com/trials/chemotherapy-radiotherapy-versus-concomitant-chemotherapy-followed-by-radiotherapy-in-stage-iiib-non-small-cell-lung-can-45391https://curecurrent.com/trials/trial-of-nanopac-intratumoral-injection-in-lung-cancer-45392https://curecurrent.com/trials/a-rct-on-the-preventive-effect-of-hfnc-on-postoperative-pulmonary-complications-in-patients-with-gynecologic-neoplasms-45393https://curecurrent.com/trials/association-of-psychological-distress-in-patients-with-lung-cancer-45394https://curecurrent.com/trials/anti-interleukin-8-anti-il-8-for-patients-with-covid-19-45395https://curecurrent.com/trials/supporting-parents-to-choose-wisely-45396https://curecurrent.com/trials/exercise-training-and-behavioral-modification-for-the-improvement-of-physical-activity-in-head-and-neck-cancer-patients-45397https://curecurrent.com/trials/analysis-of-drug-resistance-in-immune-checkpoint-inhibitors-of-non-small-cell-lung-cancer-45398https://curecurrent.com/trials/molecular-landscape-analysis-and-clinical-implications-for-nsclc-patients-with-rare-mutations-45399https://curecurrent.com/trials/a-study-of-the-effects-of-alks-4230-nemvaleukin-alfa-on-subjects-with-solid-tumors-45400https://curecurrent.com/trials/pembrolizumab-and-trametinib-in-treating-patients-with-stage-iv-non-small-cell-lung-cancer-and-kras-gene-mutations-45401https://curecurrent.com/trials/vebreltinib-plus-plb1004-in-egfr-mutated-advanced-nsclc-with-met-amplification-or-met-overexpression-following-egfr-tki-45402https://curecurrent.com/trials/a-clinical-study-on-the-efficacy-and-safety-of-the-combination-of-limertinib-and-bevacizumab-versus-limertinib-as-first-45403https://curecurrent.com/trials/vebreltinib-plus-plb1004-as-the-first-line-therapy-for-patients-with-egfrm-met-locally-advanced-or-metastatic-nsclc-45404https://curecurrent.com/trials/rucaparib-in-treating-patients-with-genomic-loh-high-and-or-deleterious-brca1-2-mutation-stage-iv-or-recurrent-non-small-45405https://curecurrent.com/trials/vebreltinib-plus-plb1004-versus-platinum-based-doublet-chemotherapy-in-patients-with-egfrm-met-locally-advanced-or-metas-45406https://curecurrent.com/trials/trial-of-ctdna-of-guidance-to-determine-postoperative-radiation-therapy-45407https://curecurrent.com/trials/proactive-outreach-and-shared-decision-making-in-improving-lung-cancer-screening-rates-in-primary-care-patients-45408https://curecurrent.com/trials/maintenance-durvalumab-medi4736-and-olaparib-azd2281-after-standard-1st-line-treatment-carboplatin-cisplatin-etoposide-d-45409https://curecurrent.com/trials/improving-lung-cancer-screening-adherence-by-overcoming-barriers-for-vulnerable-populations-45410https://curecurrent.com/trials/apixaban-in-preventing-secondary-cancer-related-venous-thrombosis-in-cancer-patients-who-have-completed-anticoagulation-45411https://curecurrent.com/trials/tgrx-326-chinese-phase-iii-for-advanced-non-small-cell-lung-cancer-nsclc-45412https://curecurrent.com/trials/tgrx-326-pharmacokinetic-food-effect-bioavailability-study-45413https://curecurrent.com/trials/perioperative-tislelizumab-for-resectable-ii-iiib-n2-kras-mutated-nonsquamous-non-small-cell-lung-cancer-45414https://curecurrent.com/trials/this-is-a-two-cohort-exploratory-clinical-study-assessing-the-activity-of-benmelstobart-combined-with-chemotherapy-with-45415https://curecurrent.com/trials/tgrx-326-chinese-phase-i-for-advanced-non-small-cell-lung-cancer-nsclc-45416https://curecurrent.com/trials/predicting-non-small-cell-lung-cancer-nsclc-lymph-node-metastasis-integrating-circulating-tumor-dna-ctdna-mutation-methy-45417https://curecurrent.com/trials/tgrx-326-chinese-phase-ii-for-advanced-non-small-cell-lung-cancer-nsclc-45418https://curecurrent.com/trials/study-of-capmatinib-efficacy-in-comparison-with-docetaxel-in-previously-treated-participants-with-non-small-cell-lung-ca-45419https://curecurrent.com/trials/application-of-extended-reality-xr-assisted-ct-guided-localization-of-pulmonary-nodules-in-thoracoscopic-sublobar-resect-45420https://curecurrent.com/trials/study-of-th-302-or-placebo-in-combination-with-pemetrexed-in-patients-with-non-squamous-non-small-cell-lung-cancer-45421https://curecurrent.com/trials/chemoembolization-for-lung-tumors-45422https://curecurrent.com/trials/early-integrated-telehealth-versus-in-person-palliative-care-for-patients-with-lung-cancer-45423https://curecurrent.com/trials/the-associations-of-sleep-disturbance-with-therapy-efficacy-and-prognosis-of-lung-cancer-45424https://curecurrent.com/trials/a-phase-1-2-study-to-evaluate-the-safety-tolerability-and-pk-of-jin-a02-in-patients-with-egfr-mutant-advanced-nsclc-45425https://curecurrent.com/trials/trial-of-trametinib-and-ponatinib-in-patients-with-kras-mutant-advanced-non-small-cell-lung-cancer-45426https://curecurrent.com/trials/a-study-of-hydroxycholoroquine-compared-to-placebo-as-treatment-for-people-with-covid-19-45427https://curecurrent.com/trials/clinical-study-of-combined-epha2-targeted-car-dc-and-car-t-cell-therapy-for-non-small-cell-lung-cancer-45428https://curecurrent.com/trials/pre-habilitation-in-lung-surgery-candidates-45429https://curecurrent.com/trials/a-pilot-study-of-dacomitinib-with-or-without-osimertinib-for-patients-with-metastatic-egfr-mutant-lung-cancers-with-dise-45430https://curecurrent.com/trials/circulating-tumor-dna-in-predicting-outcomes-in-patients-with-stage-iv-head-and-neck-cancer-or-stage-iii-iv-non-small-ce-45431https://curecurrent.com/trials/niraparib-efficacy-in-patient-with-unresectable-mesothelioma-45432https://curecurrent.com/trials/automated-device-for-asthma-monitoring-and-management-in-monitoring-adults-with-lung-cancer-undergoing-radiation-therapy-45433https://curecurrent.com/trials/bovine-reinforcement-in-stomach-colorectal-and-lung-operation-45434https://curecurrent.com/trials/radiation-therapy-and-mk-3475-for-patients-with-recurrent-metastatic-head-and-neck-cancer-renal-cell-cancer-melanoma-and-45435https://curecurrent.com/trials/apalutamide-plus-cetrelimab-in-patients-with-treatment-emergent-small-cell-neuroendocrine-prostate-cancer-45436https://curecurrent.com/trials/analysis-of-biopsy-specimens-to-study-responses-to-pd-1-or-pd-l1-therapies-45437https://curecurrent.com/trials/continued-access-to-rxdx-105-45438https://curecurrent.com/trials/exploratory-study-of-the-microbiome-of-upper-gastrointestinal-in-the-pathogenesis-of-multiple-primary-lung-cancer-45439https://curecurrent.com/trials/bronchial-mapping-gcc-1635-45440https://curecurrent.com/trials/survivorship-study-of-cancer-patients-who-received-cranial-radiation-therapy-45441https://curecurrent.com/trials/mwa-with-or-without-furmonertinib-for-early-stage-non-small-cell-lung-cancer-45442https://curecurrent.com/trials/rapa-201-therapy-of-solid-tumors-45443https://curecurrent.com/trials/a-study-of-sys6040-for-injection-in-patients-with-advanced-solid-tumors-45444https://curecurrent.com/trials/study-of-irx4204-with-erlotinib-in-previously-treated-advanced-nsclc-45445https://curecurrent.com/trials/high-dose-firmonertinib-combined-with-bevacizumab-and-intrathecal-pemetrexed-in-the-treatment-of-egfr-mutated-non-small-45446https://curecurrent.com/trials/navigation-endobronchial-ultrasound-45447https://curecurrent.com/trials/a-novel-method-for-treating-lung-met-w-combo-of-electric-fields-rad-therapy-a-single-arm-45448https://curecurrent.com/trials/piloting-mpal-a-multilevel-strategy-for-palliative-care-implementation-45449https://curecurrent.com/trials/phase-1-2-study-of-apr-246-in-combination-with-pembrolizumab-in-subjects-with-solid-tumor-malignancies-45450https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-safety-pharmacokinetics-and-antitumor-activity-of-hc010-in-patients-with-advanced-solid-45451https://curecurrent.com/trials/efficacy-of-torque-teno-virus-as-a-biomarker-for-predicting-treatment-response-of-immune-checkpoint-inhibitor-therapy-an-45452https://curecurrent.com/trials/phase-i-ii-trial-of-alectinib-and-bevacizumab-in-patients-with-advanced-anaplastic-lymphoma-kinase-alk-positive-non-smal-45453https://curecurrent.com/trials/tislelizumab-in-cancer-patients-with-molecular-residual-disease-45454https://curecurrent.com/trials/using-a-targeted-cancer-vaccine-galinpepimut-s-with-immunotherapy-nivolumab-in-mesothelioma-45455https://curecurrent.com/trials/nad-supplement-nmn-with-radioimmunotherapy-in-advanced-nsclc-45456https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-anlotinib-combined-with-furmonertinib-mesylate-in-lung-cancer-45457https://curecurrent.com/trials/tetracycline-as-a-prophylaxis-for-rash-in-patients-with-nsclc-receiving-treatment-with-bibw2992-afatinib-45458https://curecurrent.com/trials/a-study-of-sea-cd40-given-with-other-drugs-in-cancers-45459https://curecurrent.com/trials/cutting-edge-imaging-technologies-to-improve-the-safety-and-the-sustainability-of-lung-cancer-screening-and-the-accuracy-45460https://curecurrent.com/trials/low-flow-vs-high-flow-nasal-cannula-for-hypoxemic-immunocompromised-patients-during-diagnostic-bronchoscopy-45461https://curecurrent.com/trials/m7824-and-topotecan-or-temozolomide-in-relapsed-small-cell-lung-cancers-45462https://curecurrent.com/trials/optimizing-post-thoracotomy-pain-management-comparing-erector-spinae-vs-paravertebral-block-in-thoracotomy-patients-45463https://curecurrent.com/trials/impact-of-psychological-stress-on-treatment-response-and-prognosis-in-lung-cancer-patients-45464https://curecurrent.com/trials/pembrolizumab-with-standard-cytotoxic-chemotherapy-in-treatment-naive-nsclc-patients-with-asymptomatic-brain-metastases-45465https://curecurrent.com/trials/novel-epigenetic-mapping-in-cell-free-dna-for-the-detection-of-lung-cancer-45466https://curecurrent.com/trials/a-phase-ib-study-of-hs-10370-in-addition-to-other-anti-cancer-therapies-in-patients-with-advanced-solid-tumors-45467https://curecurrent.com/trials/surufatinib-in-combination-with-tislelizumab-in-subjects-with-advanced-solid-tumors-45468https://curecurrent.com/trials/sotorasib-in-previously-treated-locally-advanced-or-metastatic-nsclc-subjects-with-mutated-kras-p-g12c-45469https://curecurrent.com/trials/the-efficacy-and-safety-of-sintilimab-plus-chemotherapy-in-surgical-conversion-for-patients-with-unresectable-stage-iiib-45470https://curecurrent.com/trials/real-world-assessment-of-therapeutic-strategies-and-survival-outcomes-following-first-line-tislelizumab-therapy-in-advan-45471https://curecurrent.com/trials/a-trial-of-durvalumab-and-tremelimumab-in-combination-with-sbrt-in-patients-with-metastatic-cancer-45472https://curecurrent.com/trials/nano-crystalline-megestrol-acetate-combined-with-standard-treatment-versus-standard-treatment-for-first-line-extensive-s-45473https://curecurrent.com/trials/clinical-study-on-nanocrystalline-megestrol-acetate-for-appetite-improvement-and-weight-gain-in-pre-cachexia-and-cachexi-45474https://curecurrent.com/trials/armstrong-air-entrainment-vs-standard-treatment-in-non-expandable-lung-45475https://curecurrent.com/trials/a-study-of-bl-b01d1-in-combination-with-osimertinib-mesylate-tablets-in-patients-with-locally-advanced-or-metastatic-non-45476https://curecurrent.com/trials/sacituzumab-govitecan-and-bevacizumab-for-nsclc-brain-metastases-45477https://curecurrent.com/trials/retrospective-clinical-trial-comparing-radiologists-diagnosis-accuracy-in-lung-cancer-screening-population-with-and-with-45478https://curecurrent.com/trials/prophylactic-peg-rhg-csf-during-ccrt-in-la-nsclc-45479https://curecurrent.com/trials/combining-electrical-impedance-tomography-and-thoracic-ultrasound-toinvestigate-dynamic-changes-45480https://curecurrent.com/trials/umbrella-trial-of-adjuvant-therapy-in-completely-resected-high-risk-stage-ia-ib-nsclc-focus-on-driver-mutations-45481https://curecurrent.com/trials/danvatirsen-and-durvalumab-in-treating-patients-with-advanced-and-refractory-pancreatic-non-small-cell-lung-cancer-and-m-45482https://curecurrent.com/trials/olaparib-in-patients-with-hrd-malignant-mesothelioma-45483https://curecurrent.com/trials/a-phase-i-ib-study-of-niz985-alone-and-in-combination-with-spartalizumab-45484https://curecurrent.com/trials/organoid-guided-personalized-treatment-of-pleural-effusion-45485https://curecurrent.com/trials/building-engagement-using-financial-incentives-trial-colorectal-cancer-screening-45486https://curecurrent.com/trials/lung-cancer-exercise-training-study-45487https://curecurrent.com/trials/zd1839-with-hypofractionated-radiation-therapy-with-an-immobilization-device-for-advanced-non-small-cell-lung-cancer-45488https://curecurrent.com/trials/alimta-carboplatin-and-radiation-therapy-for-non-small-cell-lung-cancer-45489https://curecurrent.com/trials/source-lung-stereotactic-ablative-radiation-therapy-of-ultracentral-lung-tumours-source-lung-45490https://curecurrent.com/trials/ak112-in-combination-with-chemotherapy-in-advanced-squamous-non-small-cell-lung-cancer-45491https://curecurrent.com/trials/a-prospective-study-the-impact-of-sleep-disturbances-on-immunotherapy-in-patients-with-lung-cancer-45492https://curecurrent.com/trials/vic-1911-monotherapy-in-combination-with-sotorasib-for-the-treatment-of-kras-g12c-mutant-non-small-cell-lung-cancer-45493https://curecurrent.com/trials/feasibility-of-bright-light-therapy-on-fatigue-sleep-and-circadian-activity-rhythms-in-lung-cancer-survivors-45494https://curecurrent.com/trials/immunonutrition-for-improving-the-efficacy-of-immunotherapy-in-patients-with-metastatic-non-small-cell-lung-cancer-45495https://curecurrent.com/trials/sleep-state-in-lung-cancer-a-retrospective-analysis-45496https://curecurrent.com/trials/prognostic-correlation-between-the-ratio-of-the-neutrophil-ratio-to-the-ratio-of-cd4-cd8-t-cells-in-patients-with-advanc-45497https://curecurrent.com/trials/study-to-evaluate-safety-and-pk-of-chs-006-in-combination-with-toripalimab-in-patients-with-advanced-solid-tumors-45498https://curecurrent.com/trials/prospective-single-arm-phase-ii-clinical-study-of-irinotecan-hydrochloride-liposome-injection-combined-with-platinum-and-45499https://curecurrent.com/trials/induction-chemo-nivo-in-unresectable-stage-iii-nsclc-45500https://curecurrent.com/trials/comparison-of-three-different-puncture-techniques-in-ebus-tbna-45501https://curecurrent.com/trials/in10018-combination-therapy-in-treatment-na-ve-es-sclc-45502https://curecurrent.com/trials/a-study-of-erlotinib-plus-radiotherapy-rt-for-patients-with-advanced-or-inoperable-non-small-cell-lung-cancer-45503https://curecurrent.com/trials/sbrt-for-oligo-residual-nsclc-after-treatment-with-pd-1-pd-l1-immune-checkpoint-inhibitors-45504https://curecurrent.com/trials/multiomics-tumor-evolution-model-of-nsclc-45505https://curecurrent.com/trials/prognostic-value-of-tumor-hypoxia-as-measured-by-18f-fmiso-breath-hold-pet-ct-in-non-small-cell-lung-cancer-nsclc-patien-45506https://curecurrent.com/trials/midrixneo-lung-dendritic-cell-vaccine-in-patients-with-non-small-cell-lung-cancer-45507https://curecurrent.com/trials/a-study-of-zenocutuzumab-mcla-128-in-patients-with-solid-tumors-harboring-an-nrg1-fusion-enrgy-45508https://curecurrent.com/trials/a-study-of-lazertinib-in-participants-with-epidermal-growth-factor-receptor-egfr-mutation-positive-advanced-non-small-ce-45509https://curecurrent.com/trials/decision-counseling-program-in-increasing-shared-decision-making-and-clinical-trial-participation-in-patients-with-stage-45510https://curecurrent.com/trials/car-t-cells-in-mesothelin-expressing-cancers-45511https://curecurrent.com/trials/srk-181-alone-or-in-combination-with-anti-pd-l-1-antibody-therapy-in-patients-with-locally-advanced-or-metastatic-solid-45512https://curecurrent.com/trials/autologous-dendritic-cell-vaccination-in-mesothelioma-45513https://curecurrent.com/trials/genetics-and-shared-decision-making-in-improving-care-for-patients-with-stage-iva-c-non-small-cell-lung-cancer-45514https://curecurrent.com/trials/first-local-anaesthesia-thoracoscopy-for-pleural-effusion-diagnosis-45515https://curecurrent.com/trials/a-real-world-study-on-the-treatment-of-non-small-cell-lung-cancer-with-leptomeningeal-metastasis-in-china-45516https://curecurrent.com/trials/second-line-regimen-combined-with-radiotherapy-versus-without-radiotherapy-in-patients-with-locally-advanced-oligometast-45517https://curecurrent.com/trials/a-study-to-evaluate-the-clinical-efficacy-of-jnj-42756493-erdafitinib-a-pan-fibroblast-growth-factor-receptor-fgfr-tyros-45518https://curecurrent.com/trials/first-in-human-study-of-bbt-207-in-advanced-non-small-cell-lung-cancer-harboring-egfr-mutation-after-treatment-with-egfr-45519https://curecurrent.com/trials/comparison-of-neoadjuvant-cadonilimab-versus-chemotherapy-combined-with-pd-1-in-the-treatment-of-resectable-non-small-ce-45520https://curecurrent.com/trials/a-study-of-smoking-cessation-patterns-in-participants-undergoing-lung-surgery-45521https://curecurrent.com/trials/dbt-for-metastatic-lung-cancer-45522https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-a2b530-a-logic-gated-car-t-in-participants-with-solid-tumors-that-express-45523https://curecurrent.com/trials/hypofractionated-radiotherapy-followed-by-chemo-immunotherapy-induction-therapy-45524https://curecurrent.com/trials/adagrasib-in-combination-with-nab-sirolimus-in-patients-with-advanced-solid-tumors-and-non-small-cell-lung-cancer-with-a-45525https://curecurrent.com/trials/descriptive-study-of-the-incidence-of-malignancy-in-severe-asthma-patients-receiving-benralizumab-and-other-biologic-the-45526https://curecurrent.com/trials/confirmation-of-accuracy-of-the-tool-in-lesion-technology-tilt-of-the-galaxy-system-with-integrated-tomo-technology-45527https://curecurrent.com/trials/sleep-disorders-and-tumor-immune-microenvironment-45528https://curecurrent.com/trials/brigatinib-plus-chemotherapy-or-local-consolidation-therapy-in-alk-positive-advanced-non-small-cell-lung-cancer-brightst-45529https://curecurrent.com/trials/bronchoscopic-cryo-immunotherapy-of-lung-cancer-45530https://curecurrent.com/trials/exploration-of-risk-factors-for-postoperative-cerebral-infarction-in-lung-cancer-patients-a-retrospective-single-centre-45531https://curecurrent.com/trials/the-effects-of-a-family-centered-tai-chi-exercise-on-lung-function-and-mental-health-of-patients-after-thoracoscopic-sur-45532https://curecurrent.com/trials/a-study-of-sapanisertib-in-relapsed-refractory-nfe2l2-mutated-and-wild-type-squamous-non-small-cell-lung-cancer-45533https://curecurrent.com/trials/evaluate-safety-and-tolerability-of-rx001-in-patients-with-kras-mutant-advanced-nsclc-45534https://curecurrent.com/trials/benmelstobart-anlotinib-and-chemotherapy-as-first-line-treatment-for-extensive-stage-small-cell-lung-cancer-45535https://curecurrent.com/trials/ef-36-keynote-b36-a-pilot-randomized-open-label-study-of-tumor-treating-fields-ttfields-150-khz-concomitant-with-pembrol-45536https://curecurrent.com/trials/bispecific-psmaxcd3-antibody-cc-1-in-patients-with-squamous-cell-carcinoma-of-the-lung-45537https://curecurrent.com/trials/a-study-of-the-oral-egfr-inhibitor-plb1004-in-non-small-cell-lung-cancer-45538https://curecurrent.com/trials/18f-labeled-fap-targeted-molecular-probe-in-early-tumor-diagnosis-45539https://curecurrent.com/trials/cryoablation-combined-with-tislelizumab-and-chemotherapy-as-neoadjuvant-and-adjuvant-therapy-in-resectable-stage-ii-iiib-45540https://curecurrent.com/trials/project-plus-lung-cancer-screening-promotion-45541https://curecurrent.com/trials/prehabilitation-for-patients-undergoing-lung-cancer-surgery-45542https://curecurrent.com/trials/telehealth-based-synchronous-navigation-to-improve-molecularly-informed-care-for-patients-with-lung-cancer-45543https://curecurrent.com/trials/neoadjuvant-nivolumab-plus-ipilimumab-in-resectable-nsclc-galaxy-3-45544https://curecurrent.com/trials/a-multicenter-single-arm-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-fulzerasib-ibi351-in-combination-with-ivo-45545https://curecurrent.com/trials/comparison-of-40-glucose-solution-and-autologous-blood-patch-pleurodesis-for-postoperative-air-leak-after-lung-resection-45546https://curecurrent.com/trials/a-safety-and-efficacy-study-of-cc-90011-in-participants-with-relapsed-and-or-refractory-solid-tumors-and-non-hodgkin-s-l-45547https://curecurrent.com/trials/study-of-efficacy-and-safety-of-cml-cp-patients-treated-with-asciminib-versus-best-available-therapy-previously-treated-45548https://curecurrent.com/trials/temple-health-chest-initiative-thci-2-0-45549https://curecurrent.com/trials/comparing-btva-and-mwa-in-copd-with-early-lung-cancer-efficacy-and-safety-45550https://curecurrent.com/trials/study-of-an-anti-her3-antibody-hmbd-001-with-or-without-chemotherapy-in-patients-with-solid-tumors-harboring-an-nrg1-fus-45551https://curecurrent.com/trials/hippocampus-avoidance-whole-brain-radiation-therapy-with-simultaneous-integrated-boost-for-bms-of-nsclc-45552https://curecurrent.com/trials/a-study-of-shr-1826-for-injection-in-combination-with-other-antitumor-therapies-in-subjects-with-nsclc-45553https://curecurrent.com/trials/local-consolidative-radiotherapy-for-oligoprogressive-in-non-small-cell-lung-carcinoma-45554https://curecurrent.com/trials/sitravatinib-plus-pembrolizumab-in-patients-with-advanced-treatment-na-ve-pd-l1-non-squamous-nsclc-45555https://curecurrent.com/trials/a-study-to-evaluate-subcutaneous-durvalumab-in-patients-with-non-small-cell-lung-cancer-and-small-cell-lung-cancer-45556https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-nintedanib-bibf-1120-prednisone-taper-in-patients-with-radiation-pneumoniti-45557https://curecurrent.com/trials/a-study-of-bms-986315-and-nivolumab-in-combination-with-chemotherapy-in-participants-with-first-line-stage-iv-or-recurre-45558https://curecurrent.com/trials/liquid-biopsy-based-novel-modality-for-postoperative-management-of-lung-cancer-45559https://curecurrent.com/trials/correlation-of-pre-and-post-operative-cancer-imaging-techniques-45560https://curecurrent.com/trials/safety-efficacy-and-survival-outcomes-of-neoadjuvant-induction-immunotherapy-in-surgical-and-radiotherapeutic-management-45561https://curecurrent.com/trials/a-trial-of-an0025-with-chemoradiation-therapy-in-stage-iii-nsclc-participants-45562https://curecurrent.com/trials/project-lung-cancer-screening-in-southern-denmark-45563https://curecurrent.com/trials/dose-escalation-of-rmc-5552-monotherapy-in-relapsed-refractory-solid-tumors-45564https://curecurrent.com/trials/prevention-of-gvhd-in-participants-with-hematological-malignancies-undergoing-hematopoietic-stem-cell-transplant-hsct-45565https://curecurrent.com/trials/breath-analysis-to-diagnose-lung-cancer-45566https://curecurrent.com/trials/a-clinical-study-of-furmonertinib-in-the-treatment-of-egfr-mutated-nsclc-with-leptomeningeal-metastases-45567https://curecurrent.com/trials/a-study-evaluating-the-effect-of-aumolertinib-on-the-pharmacokinetics-of-midazolam-in-patients-with-nsclc-45568https://curecurrent.com/trials/a-phase-ib-study-of-lxh254-centric-combinations-in-nsclc-or-melanoma-45569https://curecurrent.com/trials/shr0302-combined-with-pd-1-pd-l1-inhibition-for-treatment-na-ve-or-acquired-resistant-to-immunology-nsclc-45570https://curecurrent.com/trials/trial-of-topotecan-with-vx-970-m6620-an-atr-kinase-inhibitor-in-small-cell-cancers-and-extrapulmonary-small-cell-cancers-45571https://curecurrent.com/trials/pilot-study-to-assess-lung-shunting-of-yttrium-90-microspheres-using-pet-ct-45572https://curecurrent.com/trials/alflutinib-mesylate-versus-gefitinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-flag-45573https://curecurrent.com/trials/pet-ct-guided-biopsy-versus-ct-guided-biopsy-in-evaluation-of-suspected-lung-neoplasms-45574https://curecurrent.com/trials/continuous-wireless-monitoring-of-vital-signs-and-automated-alerts-in-participants-at-home-and-during-hospitalization-45575https://curecurrent.com/trials/an-open-label-trial-of-afatinib-giotrif-in-treatment-naive-1st-line-or-chemotherapy-pre-treated-patients-with-locally-ad-45576https://curecurrent.com/trials/phase-1b-2a-open-label-study-of-vactosertib-in-combination-with-durvalumab-in-advanced-nsclc-45577https://curecurrent.com/trials/xp-102-and-xp-102-in-combination-with-trametinib-in-advanced-solid-tumor-patients-with-a-braf-v600-mutation-45578https://curecurrent.com/trials/breath-analysis-for-the-detection-of-invasive-fungal-infections-45579https://curecurrent.com/trials/ultrasound-guided-cryobiopsy-of-mediastinal-hilar-lymph-nodes-45580https://curecurrent.com/trials/lung-cancer-registry-45581https://curecurrent.com/trials/statin-treatment-for-covid-19-to-optimise-neurological-recovery-45582https://curecurrent.com/trials/development-of-the-drug-and-alcohol-respiratory-health-test-45583https://curecurrent.com/trials/personalizing-adoptive-cell-transfer-for-solid-tumors-towards-a-new-patient-tailored-treatment-option-45584https://curecurrent.com/trials/a2r-and-ectonucleotidases-expression-in-lung-cancer-circulating-tumor-cells-45585https://curecurrent.com/trials/18f-fspg-pet-ct-in-diagnosing-early-lung-cancer-in-patients-with-lung-nodules-45586https://curecurrent.com/trials/phase-ib-trial-of-hs-20117-in-combination-with-other-drugs-in-advanced-solid-tumors-45587https://curecurrent.com/trials/a-study-of-bms-986416-with-and-without-nivolumab-in-select-solid-tumors-45588https://curecurrent.com/trials/current-practice-of-ventilation-strategies-in-children-undergoing-general-anesthesia-45589https://curecurrent.com/trials/real-world-experience-with-combination-chemotherapy-and-osimertinib-in-poor-prognostic-group-of-metastatic-egfr-mutated-45590https://curecurrent.com/trials/dolce-determining-the-impact-of-optellum-s-lung-cancer-prediction-solution-45591https://curecurrent.com/trials/m7824-versus-pembrolizumab-as-a-first-line-1l-treatment-in-participants-with-programmed-death-ligand-1-pd-l1-expressing-45592https://curecurrent.com/trials/rafist-a-radiomics-based-tool-for-intratumoral-fibrosis-stratification-in-non-small-cell-lung-cancer-45593https://curecurrent.com/trials/supportive-care-needs-of-bronchial-cancer-patients-in-active-treatment-a-descriptive-study-in-outpatient-oncology-45594https://curecurrent.com/trials/telerehabilitation-in-lung-surgery-patients-45595https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-glumetinib-combined-with-osimertinib-mesylate-versus-platinum-based-doubl-45596https://curecurrent.com/trials/predictive-value-of-pet-ct-for-efficacy-of-neoadjuvant-immunotherapy-in-non-small-cell-lung-cancer-45597https://curecurrent.com/trials/hemithoracic-arc-radiotherapy-post-pleural-decortication-45598https://curecurrent.com/trials/study-of-mrtx1133-in-patients-with-advanced-solid-tumors-harboring-a-kras-g12d-mutation-45599https://curecurrent.com/trials/does-continuous-vital-sign-monitoring-increase-investigations-and-interventions-in-complication-free-patients-45600https://curecurrent.com/trials/patient-reported-unmet-needs-for-function-and-supportive-occupational-and-physiotherapy-rehabilitation-interventions-45601https://curecurrent.com/trials/ab-16b5-combined-with-docetaxel-in-subjects-with-metastatic-non-small-cell-lung-cancer-egia-002-45602https://curecurrent.com/trials/preventing-viral-pandemic-associated-risk-of-cancer-death-using-less-invasive-diagnostic-tests-liquid-biopsies-45603https://curecurrent.com/trials/adagrasib-in-combination-with-tno155-in-patients-with-cancer-krystal-2-45604https://curecurrent.com/trials/study-of-serplulimab-plus-chemotherapy-as-neoadjuvant-therapy-for-limited-stage-small-cell-lung-cancer-ls-sclc-45605https://curecurrent.com/trials/feasibility-study-to-treat-lung-cancer-with-the-permanently-implantable-ldr-civasheet-45606https://curecurrent.com/trials/efficacy-and-safety-study-of-pembrolizumab-mk-3475-with-or-without-lenvatinib-mk-7902-e7080-in-adults-with-programmed-ce-45607https://curecurrent.com/trials/investigation-of-respiratory-related-tumour-motion-in-liver-cancer-patients-undergoing-sbrt-using-audiovisual-biofeedbac-45608https://curecurrent.com/trials/neoadjuvant-anti-pd-1-immunotherapy-in-resectable-non-small-cell-lung-cancer-45609https://curecurrent.com/trials/efficacy-and-safety-of-alflutinib-in-locally-advanced-or-metastatic-non-small-cell-lung-cancer-patients-with-t790m-45610https://curecurrent.com/trials/nanocrystalline-megestrol-acetate-for-the-treatment-of-anorexia-cachexia-syndrome-in-extensive-stage-small-cell-lung-can-45611https://curecurrent.com/trials/ast2818-in-advanced-non-small-cell-lung-cancer-with-egfr-mutations-45612https://curecurrent.com/trials/a-phase-3-study-of-99mtc-ec-dg-spect-ct-versus-pet-ct-in-lung-cancer-45613https://curecurrent.com/trials/quality-of-life-as-a-predictor-of-os-and-pfs-in-patients-with-lung-cancer-45614https://curecurrent.com/trials/integrating-surgery-and-radiotherapy-following-tislelizumab-based-conversion-therapy-in-n3-stage-iii-nsclc-45615https://curecurrent.com/trials/anti-cea-car-t-for-advanced-cea-positive-lung-carcinoma-45616https://curecurrent.com/trials/effects-of-ba-duan-jin-for-patients-with-pulmonary-nodules-45617https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-anti-tumour-activity-of-alflutinib-in-advanced-non-small-cell-lung-cancer-45618https://curecurrent.com/trials/genotyping-of-ebus-tbna-supernant-cell-free-dna-in-nsclc-45619https://curecurrent.com/trials/glumetinib-combined-with-osimertinib-treatment-for-non-small-cell-lung-cancer-patients-45620https://curecurrent.com/trials/sl-279252-pd1-fc-ox40l-in-subjects-with-advanced-solid-tumors-or-lymphomas-45621https://curecurrent.com/trials/study-of-pemetrexed-platinum-chemotherapy-with-or-without-cosibelimab-in-first-line-metastatic-non-squamous-nsclc-45622https://curecurrent.com/trials/neo-diana-neoadjuvant-treatment-for-egfr-mutated-patients-45623https://curecurrent.com/trials/exploratory-biomarker-analysis-of-neoadjuvant-chemoimmunotherapy-followed-by-pulmonary-resection-in-stage-ii-iii-non-sma-45624https://curecurrent.com/trials/in-vivo-egfr-molecular-classification-and-treatment-response-45625https://curecurrent.com/trials/cprit-patient-adherence-to-lung-cancer-screening-45626https://curecurrent.com/trials/binimetinib-and-hydroxychloroquine-in-patients-with-advanced-kras-mutant-non-small-cell-lung-cancer-45627https://curecurrent.com/trials/lorlatinib-after-failure-of-first-line-second-generation-alk-kinase-inhibitor-in-patients-with-advanced-alk-positive-non-45628https://curecurrent.com/trials/combined-deep-inspiration-breath-hold-dibh-expiration-planning-technique-in-patients-with-lung-tumors-in-close-proximity-45629https://curecurrent.com/trials/nivolumab-ipilimumab-in-patients-with-advanced-refractory-pulmonary-or-gastroenteropancreatic-poorly-differentiated-neur-45630https://curecurrent.com/trials/collection-of-sputum-and-labeling-for-lung-cancer-45631https://curecurrent.com/trials/giessen-pulmonary-hypertension-in-lung-cancer-registry-45632https://curecurrent.com/trials/de-escalation-immunotherapy-maintenance-duration-trial-for-stage-iv-lung-cancer-patients-with-disease-control-after-chem-45633https://curecurrent.com/trials/description-of-the-population-with-genitourinary-tumors-and-covid-19-45634https://curecurrent.com/trials/hypofractionated-radiation-therapy-to-improve-immunotherapy-response-in-non-small-cell-lung-cancer-45635https://curecurrent.com/trials/sers-based-serum-molecular-spectral-screening-for-benign-and-malignant-pulmonary-proliferative-nodules-45636https://curecurrent.com/trials/sers-based-serum-molecular-spectral-screening-for-hematogenous-metastasis-45637https://curecurrent.com/trials/sers-based-serum-molecular-spectral-detection-of-invasive-lung-cancer-45638https://curecurrent.com/trials/molecular-imaging-of-fap-expressing-cancer-associated-fibroblasts-in-nsclc-treated-with-immune-checkpoint-inhibitors-45639https://curecurrent.com/trials/sers-based-serum-molecular-spectral-screening-for-lung-cancer-type-45640https://curecurrent.com/trials/sers-sensor-based-on-cha-reaction-for-egfr-mutation-typing-in-advanced-lung-cancer-45641https://curecurrent.com/trials/revlimid-capsules-drug-use-results-surveillance-relapsed-or-refractory-atll-45642https://curecurrent.com/trials/clinical-validation-and-benchmarking-of-top-performing-ctdna-diagnostics-stage-iii-nsclc-45643https://curecurrent.com/trials/a-study-to-learn-about-the-effectiveness-of-cancer-medicines-in-patients-with-metastatic-non-small-cell-lung-cancer-in-n-45644https://curecurrent.com/trials/serologic-response-to-the-sars-cov-2-covid-19-mrna-1273-vaccine-in-select-subsets-of-oncology-patients-45645https://curecurrent.com/trials/evaluation-of-18f-alf-nota-pcp2-pet-ct-for-pd-l1-detection-in-malignant-tumors-45646https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-pemetrexed-combined-with-nivolumab-via-intraventricular-injection-for-the-treatmen-45647https://curecurrent.com/trials/combining-afatinib-and-concurrent-chemotherapy-followed-by-osimertinib-and-concurrent-chemotherapy-in-untreated-egfr-pos-45648https://curecurrent.com/trials/comparing-different-sizes-of-small-bore-chest-drains-in-malignant-pleural-effusion-45649https://curecurrent.com/trials/chest-lymph-node-sampling-in-patients-with-advanced-lung-cancer-to-be-treated-with-curative-intent-radiation-treatment-45650https://curecurrent.com/trials/long-term-follow-up-of-checkpoint-inhibitors-induced-ileo-colitis-45651https://curecurrent.com/trials/a-study-of-rgx-104-in-patients-with-advanced-lung-endometrial-cancer-45652https://curecurrent.com/trials/identification-of-multiple-pulmonary-diseases-using-volatile-organic-compounds-biomarkers-in-human-exhaled-breath-45653https://curecurrent.com/trials/cisplatin-cis-administered-as-dry-powder-for-inhalation-dpi-in-patients-with-stage-iv-non-small-cell-lung-cancer-45654https://curecurrent.com/trials/liquid-biopsy-assay-of-ebus-tbna-supernatant-fluid-for-diagnosing-lung-cancer-45655https://curecurrent.com/trials/a-study-to-investigate-the-safety-pharmacokinetics-and-clinical-activity-of-ap203-in-patients-with-locally-advanced-or-m-45656https://curecurrent.com/trials/pulmonary-physiology-and-systemic-inflammatory-in-eo-pulmonary-events-with-brigatinib-use-in-nsclc-and-other-diseases-45657https://curecurrent.com/trials/explore-the-mechanisms-underlying-disease-resistance-and-potential-primary-resistance-mechanism-of-induction-therapy-lor-45658https://curecurrent.com/trials/cardiopulmonary-toxicity-of-thoracic-radiotherapy-45659https://curecurrent.com/trials/a-trial-of-pembrolizumab-in-combination-with-chemotherapy-and-radiotherapy-in-stage-iii-nsclc-keynote-799-mk-3475-799-45660https://curecurrent.com/trials/a-study-of-bemarituzumab-monotherapy-and-combination-with-other-anti-cancer-therapy-in-sqnsclc-with-fgfr2b-overexpressio-45661https://curecurrent.com/trials/ono-4538-study-in-patients-with-advanced-non-small-cell-lung-cancer-45662https://curecurrent.com/trials/evaluation-of-a-scalable-decision-support-and-shared-decision-making-tool-for-lung-cancer-screening-45663https://curecurrent.com/trials/percutaneous-thermal-ablation-in-lung-tumors-45664https://curecurrent.com/trials/re-challenge-pembrolizumab-study-as-a-second-or-further-line-in-patients-with-advanced-nsclc-45665https://curecurrent.com/trials/a-multicenter-clinical-trial-of-sputum-dna-testing-for-lung-cancer-in-china-45666https://curecurrent.com/trials/clinical-trial-of-yh25448-in-patients-with-egfr-mutation-positive-advanced-nsclc-45667https://curecurrent.com/trials/phase-ii-concurrent-durvalumab-and-radiotherapy-for-for-stage-iii-non-small-cell-lung-cancer-45668https://curecurrent.com/trials/firmonertinib-combined-with-chemotherapy-as-neoadjuvant-therapy-for-resectable-stage-b-egfr-sensitive-mutanted-nsclc-45669https://curecurrent.com/trials/abequolixron-rgx-104-and-durvalumab-in-lung-cancer-45670https://curecurrent.com/trials/ph1b-2-dose-escalation-study-of-entinostat-with-pembrolizumab-in-non-small-cell-lung-cancer-nsclc-with-expansion-cohorts-45671https://curecurrent.com/trials/utilizing-long-read-sequencing-to-investigate-the-egfr-landscape-of-egfr-positive-lung-cancer-patients-45672https://curecurrent.com/trials/study-of-mcla-129-in-the-treatment-of-advanced-non-small-cell-lung-cancer-with-aga-and-met-amplification-45673https://curecurrent.com/trials/nous-pev-a-novel-immunotherapy-for-lung-cancer-and-melanoma-45674https://curecurrent.com/trials/genetic-susceptibility-in-malignant-pleural-mesothelioma-clinical-implication-of-germline-variations-45675https://curecurrent.com/trials/an-open-label-single-arm-clinical-study-of-stapokibart-injection-in-combination-with-tislelizumab-injection-in-patients-45676https://curecurrent.com/trials/multimodal-prehabilitation-in-patients-with-lung-cancer-undergoing-neoadjuvant-therapy-45677https://curecurrent.com/trials/a-smart-self-management-support-programme-3s-to-improve-quality-of-life-in-lung-cancer-patients-45678https://curecurrent.com/trials/efficacy-and-safety-of-sintilimab-combined-with-platinum-containing-double-agent-chemotherapy-in-first-line-treatment-of-45679https://curecurrent.com/trials/genomic-and-methylation-markers-in-sclc-and-lcnec-for-chemo-immunotherapy-resistance-prediction-stratus-45680https://curecurrent.com/trials/relative-bioavailability-bioequivalence-of-different-formulations-of-selinexor-the-impact-of-hepatic-impairment-on-selin-45681https://curecurrent.com/trials/safety-pharmacokinetics-pharmacodynamics-and-preliminary-efficacy-trial-of-bnt411-45682https://curecurrent.com/trials/a-study-of-bms-986442-with-nivolumab-with-or-without-chemotherapy-in-solid-tumors-and-non-small-cell-lung-cancer-45683https://curecurrent.com/trials/high-intensity-aerobic-exercise-training-and-immune-cell-mobilization-in-patients-with-lung-cancer-hi-aim-45684https://curecurrent.com/trials/rrx-001-in-lung-cancer-ovarian-cancer-and-neuroendocrine-tumors-prior-to-re-administration-of-platinum-based-doublet-reg-45685https://curecurrent.com/trials/to-compare-efficacy-and-safety-of-ct-p16-and-european-union-approved-avastin-as-first-line-treatment-for-metastatic-or-r-45686https://curecurrent.com/trials/inpatient-capture-a-mixed-methods-study-to-develop-an-inpatient-lung-cancer-screening-program-in-a-safety-net-hospital-45687https://curecurrent.com/trials/phase-ib-study-of-furmonertinib-in-patients-with-nsclc-having-exon-20-insertion-mutation-45688https://curecurrent.com/trials/lorlatinib-related-hyperlipidemia-in-alk-non-small-cell-lung-cancer-45689https://curecurrent.com/trials/volatile-anaesthesia-and-perioperative-outcomes-related-to-cancer-the-vapor-c-trial-45690https://curecurrent.com/trials/study-of-incb086550-in-select-solid-tumors-45691https://curecurrent.com/trials/phase-ii-study-of-chemotherapy-and-pd-1-inhibitor-combination-with-autologous-cik-cell-immunotherapy-to-treat-lung-cance-45692https://curecurrent.com/trials/perioperative-troponin-i-and-nt-pro-bnp-in-lung-resection-45693https://curecurrent.com/trials/atezolizumab-and-rechallenge-chemotherapy-in-relapsed-patients-with-extensive-stage-small-cell-lung-cancer-es-sclc-45694https://curecurrent.com/trials/atezolizumab-versus-placebo-for-the-adjuvant-treatment-of-malignant-pleural-mesothelioma-atezomeso-45695https://curecurrent.com/trials/tislelizumab-in-addition-to-bace-in-patients-with-nsclc-45696https://curecurrent.com/trials/ali-acute-lung-injury-ards-acute-respiratory-distress-syndrome-in-oncologic-pediatric-patients-45697https://curecurrent.com/trials/a-study-of-ak104-in-subjects-with-unresectable-locally-advanced-nsclc-45698https://curecurrent.com/trials/a-study-of-ak104-in-combination-with-chiauranib-in-patients-with-extensive-stage-small-cell-lung-cancer-45699https://curecurrent.com/trials/a-study-of-pm8002-anti-pd-l1-vegf-in-combination-with-chemotherapy-in-patients-with-es-sclc-45700https://curecurrent.com/trials/elimination-of-ptv-margins-based-on-online-adaptive-stereotactic-radiotherapy-for-centrally-located-early-stage-non-smal-45701https://curecurrent.com/trials/the-lived-experiences-of-persons-with-early-stage-non-small-cell-lung-cancer-and-their-significant-other-s-following-sur-45702https://curecurrent.com/trials/evaluation-of-platelet-aggregability-in-patients-with-non-small-cell-lung-carcinomas-45703https://curecurrent.com/trials/swiss-severe-asthma-register-45704https://curecurrent.com/trials/real-life-study-evaluating-the-clinical-and-organisational-impact-of-moovcare-lung-connected-medical-device-in-lung-canc-45705https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-anti-pd-1-antibody-ak105-in-patients-with-selected-advanced-solid-tumors-45706https://curecurrent.com/trials/improving-pediatric-covid-19-vaccine-uptake-using-an-mhealth-tool-45707https://curecurrent.com/trials/prediction-of-response-to-pd-l1-inhibitor-after-chemoradiotherapy-in-limited-stage-small-cell-lung-cancer-using-multi-om-45708https://curecurrent.com/trials/optimal-duration-of-anticoagulation-therapy-for-low-risk-pulmonary-embolism-patients-with-cancer-45709https://curecurrent.com/trials/99mtc-labeled-fap-targeted-molecular-probe-in-early-diagnosis-of-tumors-45710https://curecurrent.com/trials/tarlatamab-amg-757-expanded-access-protocol-for-advanced-small-cell-lung-cancer-45711https://curecurrent.com/trials/atl001-in-patients-with-advanced-unresectable-or-metastatic-nsclc-45712https://curecurrent.com/trials/a-study-of-ladiratuzumab-vedotin-in-advanced-solid-tumors-45713https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-pharmacokinetics-pharmacodynamics-and-preliminary-anti-tumor-activity-of-ro76167-45714https://curecurrent.com/trials/an-open-label-dose-escalation-study-to-investigate-the-safety-pharmacokinetics-pharmacodynamics-and-clinical-activity-of-45715https://curecurrent.com/trials/phase-ii-clinical-study-of-befotertinib-in-egfr-non-classical-mutant-nsclc-45716https://curecurrent.com/trials/phase-i-ii-of-oral-vorinostat-combination-with-erlotinib-in-nsclc-patients-with-egfr-mutations-with-dp-after-erlotinib-45717https://curecurrent.com/trials/overcoming-resistance-to-egfr-neutralization-by-combination-of-monoclonal-antibodies-and-novel-cancer-drugs-45718https://curecurrent.com/trials/lung-nodule-detection-using-ultra-long-fov-pet-ct-45719https://curecurrent.com/trials/savolitinib-for-treating-locally-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-patients-45720https://curecurrent.com/trials/mgd019-dart-protein-in-unresectable-metastatic-cancer-45721https://curecurrent.com/trials/liver-transplantation-for-unresectable-intrahepatic-colangiocarcinoma-after-sustained-response-to-neoadjuvant-treatments-45722https://curecurrent.com/trials/evaluating-high-dose-furmonertinib-with-bevacizumab-and-pemetrexed-for-egfrm-nsclc-with-leptomeningeal-metastasis-45723https://curecurrent.com/trials/bibf-1120-in-combination-with-pemetrexed-in-advanced-non-small-cell-lung-cancer-nsclc-45724https://curecurrent.com/trials/taste-and-smell-dysfunction-in-patients-more-than-two-years-after-start-of-immune-checkpoint-inhibitor-therapy-45725https://curecurrent.com/trials/phase-iii-study-tarceva-vs-chemotherapy-to-treat-advanced-non-small-cell-lung-cancer-in-patients-with-mutations-in-the-t-45726https://curecurrent.com/trials/a-prospective-study-for-the-early-diagnosis-of-lung-cancer-in-korean-females-45727https://curecurrent.com/trials/lorlatinib-compared-with-concurrent-sequential-chemoradiotherapy-in-stage-iii-alk-positive-lung-adenocarcinoma-45728https://curecurrent.com/trials/tipifarnib-in-advanced-squamous-nsclc-with-oncogen-hras-mutations-45729https://curecurrent.com/trials/safety-study-for-a-gamma-delta-t-cell-product-used-with-low-dose-radiotherapy-in-patients-with-locally-advanced-or-metas-45730https://curecurrent.com/trials/the-efficacy-and-safety-of-the-bispecific-anti-pd-1-pd-l1-antibody-ibi318-combined-with-lenvatinib-in-nsclc-45731https://curecurrent.com/trials/feasibility-of-etco-changes-during-passive-leg-raise-for-fluid-management-in-lung-surgery-45732https://curecurrent.com/trials/pre-incisional-ketorolac-for-patients-undergoing-surgery-for-non-small-cell-lung-cancer-and-renal-cell-carcinoma-45733https://curecurrent.com/trials/safety-and-tolerability-evaluation-of-sintilimab-in-combination-with-radiation-in-stage-iv-nsclc-patients-45734https://curecurrent.com/trials/construction-of-a-prognostic-and-prediction-model-for-perioperative-immunotherapy-in-nsclc-a-multi-omics-perspective-45735https://curecurrent.com/trials/erlotinib-hydrochloride-and-onalespib-lactate-in-treating-patients-with-recurrent-or-metastatic-egfr-mutant-non-small-ce-45736https://curecurrent.com/trials/a-prospective-study-investigating-the-relationship-between-minimal-residual-disease-detection-monitoring-frequency-and-p-45737https://curecurrent.com/trials/nap-in-combination-with-docetaxel-following-obinutuzumab-pretreatment-in-subjects-with-checkpoint-inhibitor-pretreated-a-45738https://curecurrent.com/trials/second-line-immunotherapy-for-es-sclc-45739https://curecurrent.com/trials/the-study-observes-afatinib-as-first-line-treatment-in-patients-with-epidermal-growth-factor-receptor-egfr-mutation-posi-45740https://curecurrent.com/trials/study-of-platinum-plus-etoposide-with-or-without-tislelizumab-in-participants-with-untreated-extensive-stage-small-cell-45741https://curecurrent.com/trials/study-of-longitudinal-plasma-pd-l1-testing-with-immunotherapy-in-lung-cancer-45742https://curecurrent.com/trials/transbronchial-biopsy-assisted-by-robot-guidance-in-the-evaluation-of-tumors-of-the-lung-45743https://curecurrent.com/trials/phase-ii-clinical-study-of-gemox-hepatic-arterial-infusion-combined-with-lenvatinib-and-toripalimab-for-advanced-and-unr-45744https://curecurrent.com/trials/personalized-dc-vaccine-for-postoperative-cancer-45745https://curecurrent.com/trials/this-is-a-two-cohort-exploratory-clinical-study-assessing-the-activity-of-benmelstobart-alone-or-combined-with-anlotinib-45746https://curecurrent.com/trials/tislelizumab-in-combination-with-chemotherapy-radiotherapy-for-extensive-stage-oligometastatic-small-cell-lung-cancer-45747https://curecurrent.com/trials/vapor-ablation-for-localized-cancer-lesions-45748https://curecurrent.com/trials/real-world-first-line-serplulimab-based-immunochemotherapy-for-extensive-stage-small-cell-lung-cancer-45749https://curecurrent.com/trials/the-regression-pattern-of-primary-lesions-in-lung-cancer-after-definitive-radiotherapy-45750https://curecurrent.com/trials/improving-genomic-profiling-and-reducing-time-to-cancer-treatment-via-targeted-use-of-endoscopic-ultrasound-45751https://curecurrent.com/trials/immunotherapy-combined-with-hypofractionated-concurrent-chemoradiotherapy-followed-by-immunotherapy-in-la-nsclc-45752https://curecurrent.com/trials/early-adjuvant-diagnosis-of-pulmonary-nodules-based-on-ctc-45753https://curecurrent.com/trials/combination-of-osimertinib-and-aspirin-to-treat-1st-generation-egfr-tki-resistance-in-nsclc-45754https://curecurrent.com/trials/xingbai-ji-formula-combined-with-chemotherapy-and-sintilimab-in-metastatic-multi-target-mutation-negative-non-small-cell-45755https://curecurrent.com/trials/brief-behavioral-intervention-for-dyspnea-in-patients-with-advanced-lung-cancer-45756https://curecurrent.com/trials/a-study-of-bgb324-bemcentinib-in-combination-with-erlotinib-in-patients-with-non-small-cell-lung-cancer-45757https://curecurrent.com/trials/dream-study-dna-rna-ngs-co-testing-in-driver-negative-treatment-resistant-nsclc-45758https://curecurrent.com/trials/mobile-3d-c-arm-ct-for-lung-tumor-localization-efficacy-analysis-a-prospective-clinical-trial-45759https://curecurrent.com/trials/alk-digital-pathology-outcome-predition-multi-institutional-restrospective-study-45760https://curecurrent.com/trials/a-study-to-compare-the-efficacy-safety-immunogenicity-and-pharmacokinetic-profile-of-hlx17-vs-keytruda-in-the-first-line-45761https://curecurrent.com/trials/the-associations-of-psychological-stress-with-therapy-efficacy-and-prognosis-of-lung-cancer-stress-lung-45762https://curecurrent.com/trials/ccp-cancer-uk-companion-study-45763https://curecurrent.com/trials/establishing-a-longitudinal-cohort-study-of-lung-cancer-using-tissue-and-peripheral-blood-metabolomics-45764https://curecurrent.com/trials/study-of-rsifn-co-for-patients-with-advanced-solid-tumors-45765https://curecurrent.com/trials/evaluation-of-a-patient-nudge-on-engagement-in-lung-cancer-screening-45766https://curecurrent.com/trials/chemotherapy-combined-with-icis-in-first-line-alectinib-failed-patients-with-alk-rearranged-nsclc-45767https://curecurrent.com/trials/tgrx-1942-chinese-phase-i-for-advanced-solid-tumor-and-or-relapsed-refractory-hematologic-malignancies-45768https://curecurrent.com/trials/evaluation-of-al3818-in-combination-with-nivolumab-in-solid-tumors-45769https://curecurrent.com/trials/tgrx-326-pharmacokinetic-mass-balance-45770https://curecurrent.com/trials/quilt-3-044-nant-non-small-cell-lung-cancer-nsclc-vaccine-combination-immunotherapy-in-subjects-with-nsclc-who-have-prog-45771https://curecurrent.com/trials/association-between-rvt-and-prognosis-after-neoadjuvant-targeted-therapy-in-egfr-nsclc-45772https://curecurrent.com/trials/additional-chemotherapy-for-egfrm-patients-with-the-continued-presence-of-plasma-ctdna-egfrm-at-week-3-after-start-of-os-45773https://curecurrent.com/trials/quilt-2-024-phase-2-neoadjuvant-consolidation-and-adjuvant-combination-nant-immunotherapy-versus-standard-of-care-in-sub-45774https://curecurrent.com/trials/early-intrapleural-tpa-instillation-versus-late-45775https://curecurrent.com/trials/neoadjuvant-chemotherapy-combined-with-bispecific-antibody-versus-monoclonal-antibody-in-locally-advanced-nsclc-45776https://curecurrent.com/trials/study-of-js004-combined-with-toripalimab-for-advanced-lung-cancer-45777https://curecurrent.com/trials/injection-of-99mtc-nanocolloid-and-icg-to-identify-retrieve-and-qualify-tdln-in-early-stage-nsclc-45778https://curecurrent.com/trials/heated-intra-peritoneal-chemotherapy-with-doxorubicin-and-cisplatin-for-abdominal-for-pelvic-tumors-in-pediatric-patient-45779https://curecurrent.com/trials/afatinib-in-nsclc-with-her2-mutation-45780https://curecurrent.com/trials/clinical-study-of-nanocrystalline-megestrol-in-malnourished-patients-with-first-line-non-small-cell-lung-cancer-45781https://curecurrent.com/trials/study-of-irinotecan-liposome-injection-onivyde-in-patients-with-small-cell-lung-cancer-45782https://curecurrent.com/trials/broncho-vascular-lung-sparing-reconstructions-and-pneumonectomies-in-patients-with-non-small-cell-lung-cancer-45783https://curecurrent.com/trials/efficacy-of-immunotherapy-plus-a-drug-in-patients-with-progressive-advanced-mucosal-cancer-of-different-locations-45784https://curecurrent.com/trials/detection-of-circulating-tumour-cells-spread-through-air-space-in-patients-with-lung-cancer-45785https://curecurrent.com/trials/efficacy-and-safety-of-cryoablation-with-robotic-bronchoscopy-system-in-patients-with-lung-cancer-45786https://curecurrent.com/trials/a-clinical-study-of-the-cryoablation-technique-for-peripheral-lung-malignancies-45787https://curecurrent.com/trials/treatable-traits-of-severe-asthma-45788https://curecurrent.com/trials/early-recovery-after-wedge-resection-surgery-to-remove-lung-mestastasis-secondary-to-bone-cancer-45789https://curecurrent.com/trials/clinical-research-platform-into-molecular-testing-treatment-and-outcome-of-non-small-cell-lung-carcinoma-patients-45790https://curecurrent.com/trials/stage-iii-nsclc-rwe-in-chinese-patients-45791https://curecurrent.com/trials/research-on-building-and-application-of-internet-based-home-pre-rehabilitation-model-for-lung-surgery-patients-45792https://curecurrent.com/trials/impact-of-non-magnetic-screen-respiratory-self-guidance-during-mri-guided-radiotherapy-sessions-for-mobile-lesions-45793https://curecurrent.com/trials/nivolumab-opdivo-plus-abi-009-nab-rapamycin-for-advanced-sarcoma-and-certain-cancers-45794https://curecurrent.com/trials/survival-outcomes-of-lung-cancer-45795https://curecurrent.com/trials/first-in-human-study-of-ovm-200-as-a-therapeutic-cancer-vaccine-45796https://curecurrent.com/trials/allogeneic-pb103-nk-cells-therapy-in-non-small-cell-lung-cancer-nsclc-patients-45797https://curecurrent.com/trials/pre-vs-postoperative-thromboprophylaxis-for-liver-resection-45798https://curecurrent.com/trials/combination-of-vebreltinib-and-osimertinib-in-patients-with-egfr-21-l858r-mutation-advanced-nsclc-45799https://curecurrent.com/trials/a-study-of-gv20-0251-monotherapy-and-gv20-0251-in-combination-with-pembrolizumab-in-participants-with-solid-tumor-malign-45800https://curecurrent.com/trials/denosumab-and-nivolumab-combination-as-2d-line-therapy-in-stage-iv-nsc-lung-cancer-with-bone-metastases-denivos-45801https://curecurrent.com/trials/lume-columbus-nintedanib-plus-docetaxel-in-advanced-non-small-cell-lung-cancer-with-translational-research-45802https://curecurrent.com/trials/early-prediction-of-therapeutic-response-to-targeted-therapy-in-stage-iiib-iv-or-recurrent-lung-cancer-patients-45803https://curecurrent.com/trials/pharmacokinetics-of-sotrovimab-as-pre-exposure-prophylaxis-for-covid-19-in-hematopoietic-stem-cell-transplant-recipients-45804https://curecurrent.com/trials/etoposide-plus-benmelstobart-followed-by-maintenance-therapy-of-benmelstobart-plus-anlotinib-in-first-line-treatment-of-45805https://curecurrent.com/trials/pharmacokinetic-study-of-hs-10365-capsule-in-subjects-with-hepatic-impairment-and-normal-hepatic-function-45806https://curecurrent.com/trials/ensuring-precision-medicine-delivery-for-veterans-with-lung-cancer-45807https://curecurrent.com/trials/orlistat-overcoming-third-generation-egfr-tki-resistance-45808https://curecurrent.com/trials/a-phase-i-ii-study-of-continuous-oral-treatment-with-bibf-1120-added-to-standard-gemcitabine-cisplatin-therapy-in-first-45809https://curecurrent.com/trials/lung-cancer-patients-and-parent-child-interaction-experience-and-process-45810https://curecurrent.com/trials/pharmacokinetic-study-of-hs-10241-tablets-in-subjects-with-hepatic-impairment-and-normal-hepatic-function-45811https://curecurrent.com/trials/intensified-chemo-immuno-radiotherapy-with-durvalumab-for-stage-iii-non-small-cell-lung-cancers-45812https://curecurrent.com/trials/osimertinib-for-nsclc-with-egfr-exon-20-insertion-mutation-45813https://curecurrent.com/trials/a-study-of-ql1706-or-ql1604-in-patients-with-limited-stage-small-cell-lung-cancer-after-chemoradiotherapy-45814https://curecurrent.com/trials/study-of-ibi3009-in-participants-with-unresectable-metastatic-or-extensive-stage-small-cell-lung-cancer-45815https://curecurrent.com/trials/irinotecan-liposome-ii-combined-with-ivonescimab-as-second-line-treatment-for-small-cell-lung-cancer-a-prospective-singl-45816https://curecurrent.com/trials/first-line-pembrolizumab-plinabulin-plus-etoposide-and-platinum-ep-for-es-sclc-45817https://curecurrent.com/trials/nintedanib-plus-docetaxel-in-japanese-patients-with-adenocarcinoma-subtype-non-small-cell-lung-cancer-after-failure-of-f-45818https://curecurrent.com/trials/csf-analysis-in-egfr-mutant-non-small-cell-lung-cancer-with-leptomeningeal-disease-45819https://curecurrent.com/trials/padeliporfin-vtp-using-robotic-assisted-bronchoscopy-in-peripheral-lung-cancer-45820https://curecurrent.com/trials/low-dose-radiotherapy-combined-with-sintilimab-and-chemotherapy-as-neoadjuvant-therapy-for-stage-ii-iii-nsclc-45821https://curecurrent.com/trials/a-study-of-sgn-alpv-in-advanced-solid-tumors-45822https://curecurrent.com/trials/comparison-of-efficacy-and-safety-of-tislelizumab-bgb-a317-versus-docetaxel-as-treatment-in-the-second-or-third-line-set-45823https://curecurrent.com/trials/chemotherapy-immunotherapy-based-split-course-adaptive-hypofractionated-radiotherapy-for-extensive-stage-sclc-45824https://curecurrent.com/trials/symphony-phase-1-2-study-targeting-egfr-resistance-mechanisms-in-nsclc-45825https://curecurrent.com/trials/concerto-study-of-blu-451-in-advanced-cancers-with-egfr-exon-20-insertion-mutations-45826https://curecurrent.com/trials/tranexamic-acid-use-for-bleeding-prevention-in-the-surgical-treatment-of-metastatic-spinal-tumor-in-lung-cancer-patients-45827https://curecurrent.com/trials/pembrolizumab-in-patients-with-non-small-cell-lung-cancer-and-a-performance-status-2-45828https://curecurrent.com/trials/asthma-in-home-monitoring-aim-trial-45829https://curecurrent.com/trials/a-study-to-learn-how-safe-the-study-drug-bay-2416964-ahr-inhibitor-in-combination-with-the-treatment-pembrolizumab-is-ho-45830https://curecurrent.com/trials/intensity-modulated-radiation-therapy-in-treating-younger-patients-with-lung-metastases-45831https://curecurrent.com/trials/biomarkers-for-clinical-classification-and-outcomes-of-immune-checkpoint-inhibitor-related-related-myocarditis-in-lung-c-45832https://curecurrent.com/trials/facilitating-communication-study-45833https://curecurrent.com/trials/a-study-of-olaparib-and-low-dose-radiotherapy-for-small-cell-lung-cancer-45834https://curecurrent.com/trials/remote-monitoring-with-health-coaching-for-lifestyle-changes-in-patients-with-lung-cancer-related-fatigue-45835https://curecurrent.com/trials/ldk378-versus-chemotherapy-in-alk-rearranged-alk-positive-patients-previously-treated-with-chemotherapy-platinum-doublet-45836https://curecurrent.com/trials/toripalimab-combined-with-anlotinib-and-sbrt-in-patients-with-untreated-brain-metastases-of-driven-gene-negative-nsclc-45837https://curecurrent.com/trials/study-of-covalent-menin-inhibitor-bmf-219-in-adult-patients-with-kras-driven-non-small-cell-lung-cancer-pancreatic-cance-45838https://curecurrent.com/trials/early-palliative-care-with-standard-care-or-standard-care-alone-in-improving-quality-of-life-of-patients-with-incurable-45839https://curecurrent.com/trials/a-study-to-learn-about-dacomitnib-in-patients-with-non-small-cell-lung-cancer-which-has-spread-to-the-brain-45840https://curecurrent.com/trials/nivolumab-with-chemotherapy-in-pleural-mesothelioma-after-surgery-45841https://curecurrent.com/trials/effectiveness-of-respiratory-muscle-training-with-a-mobile-application-after-lobectomy-45842https://curecurrent.com/trials/retrospective-observational-study-on-prediction-of-response-to-pd-1-immunotherapy-in-patients-with-nsclc-45843https://curecurrent.com/trials/circulating-and-molecular-markers-involved-in-the-processes-of-cachexia-anorexia-and-sarcopenia-in-patients-with-nsclc-45844https://curecurrent.com/trials/evaluation-of-ucpvax-plus-nivolumab-as-second-line-therapy-in-advanced-non-small-cell-lung-cancer-45845https://curecurrent.com/trials/liquid-biopsy-to-reduce-time-to-treatment-for-advanced-nonsquamous-nsclc-diagnosed-at-outside-sites-45846https://curecurrent.com/trials/the-beneficial-value-of-pet-ct-in-the-follow-up-of-stage-iii-non-small-cell-lung-cancer-patients-45847https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-tislelizumab-versus-chemotherapy-in-advanced-non-squamous-non-small-cell-l-45848https://curecurrent.com/trials/an-observational-study-to-evaluate-the-clinical-utility-of-the-oncomine-precision-assay-within-the-exactis-network-45849https://curecurrent.com/trials/actolog-in-patients-with-solid-cancers-45850https://curecurrent.com/trials/tissue-engineering-approaches-to-treat-copd-45851https://curecurrent.com/trials/an-efficacy-and-safety-study-of-jnj-64041757-a-live-attenuated-listeria-monocytogenes-immunotherapy-in-combination-with-45852https://curecurrent.com/trials/transcriptional-framework-for-the-molecular-diagnosis-of-response-to-immunotherapy-in-lung-cancer-with-agnostic-potentia-45853https://curecurrent.com/trials/tocilizumab-for-patients-with-cancer-and-covid-19-disease-45854https://curecurrent.com/trials/pulmonary-rehabilitation-before-lung-cancer-resection-45855https://curecurrent.com/trials/phase-1-study-of-ck-301-cosibelimab-as-a-single-agent-in-subjects-with-advanced-cancers-45856https://curecurrent.com/trials/study-of-osimertinib-in-patients-with-a-lung-cancer-with-brain-or-leptomeningeal-metastases-with-egfr-mutation-45857https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-jnj-42756493-in-adult-participants-with-advanced-45858https://curecurrent.com/trials/safety-immunogenicity-of-jnj-64041757-live-attenuated-double-deleted-listeria-immunotherapy-in-subjects-with-non-small-c-45859https://curecurrent.com/trials/a-study-of-robot-assisted-bronchoscopy-in-chinese-participants-with-lung-lesions-45860https://curecurrent.com/trials/study-of-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-duvortuxizumab-jnj-64052781-plus-ibrutinib-in-lymp-45861https://curecurrent.com/trials/prehabilitation-for-lung-cancer-patients-undergoing-lung-resection-45862https://curecurrent.com/trials/proteomics-in-small-cell-lung-cancer-45863https://curecurrent.com/trials/impact-of-covid-19-on-gu-disease-45864https://curecurrent.com/trials/facilitators-and-barriers-to-cancer-screening-stakeholder-perspectives-on-implementation-45865https://curecurrent.com/trials/avelumab-in-first-line-nsclc-javelin-lung-100-45866https://curecurrent.com/trials/digital-lifestyle-intervention-for-lung-cancer-survivors-45867https://curecurrent.com/trials/immunotherapy-and-stereotactic-ablative-radiotherapy-immunosabr-a-phase-ii-study-45868https://curecurrent.com/trials/thoracic-radiotherapy-with-atezolizumab-in-small-cell-lung-cancer-extensive-disease-45869https://curecurrent.com/trials/risk-factors-for-aki-in-patients-undergoing-vats-for-pulmonary-resection-45870https://curecurrent.com/trials/phase-2-platform-study-in-patients-with-advanced-non-small-lung-cancer-who-progressed-on-first-line-osimertinib-therapy-45871https://curecurrent.com/trials/ofatumumab-ibrutinib-allogeneic-bone-marrow-transplant-or-consolidation-in-high-risk-chronic-lymphocytic-leukemia-45872https://curecurrent.com/trials/evaluation-of-the-use-of-the-fur-to-quantify-tumor-glucose-consumption-in-oncologic-pet-45873https://curecurrent.com/trials/multiple-dosing-of-mesenchymal-stromal-cells-in-patients-with-ards-covid-19-45874https://curecurrent.com/trials/18f-fdg-and-68ga-fapi-pet-ct-in-lung-adenocarcinoma-45875https://curecurrent.com/trials/a-study-to-investigate-14c-bemcentinib-in-healthy-male-subjects-45876https://curecurrent.com/trials/a-study-to-assess-prevalence-of-a-specific-protein-overexpression-in-adult-participants-with-non-small-cell-lung-cancer-45877https://curecurrent.com/trials/the-effect-of-nurse-navigation-program-on-lung-cancer-patients-45878https://curecurrent.com/trials/durvalumab-and-low-dose-pci-vs-durvalumab-and-observation-in-radically-treated-patients-with-stage-iii-nsclc-nvalt28-45879https://curecurrent.com/trials/a-study-to-evaluate-guideline-adoption-through-quality-improvement-project-qip-in-pulmonary-and-critical-care-medicine-p-45880https://curecurrent.com/trials/a-study-of-mrna-5671-v941-as-monotherapy-and-in-combination-with-pembrolizumab-v941-001-45881https://curecurrent.com/trials/osimertinib-azd9291-in-first-line-locally-advanced-or-metastatic-nsclc-patients-with-egfr-and-egfr-t790m-45882https://curecurrent.com/trials/evaluation-of-a-pragmatic-approach-to-adoptive-cell-therapy-act-using-an-il2-analog-anv419-vs-high-dose-il2-after-tumor-45883https://curecurrent.com/trials/vemurafenib-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-non-hodgkin-lymphoma-or-histiocytic-d-45884https://curecurrent.com/trials/evaluating-modifiable-biomarkers-for-the-prediction-of-immunotherapy-response-and-toxicity-45885https://curecurrent.com/trials/efficacy-and-safety-of-ibi351-in-combination-with-chemotherapy-in-advanced-non-squamous-non-small-cell-lung-cancer-subje-45886https://curecurrent.com/trials/survival-outcome-of-egfr-tki-in-uncommon-egfr-mutant-advanced-nsclc-45887https://curecurrent.com/trials/a-study-of-al8326-in-non-small-cell-lung-cancer-45888https://curecurrent.com/trials/cadonilimab-in-patients-pts-with-advanced-non-small-cell-lung-cancer-nsclc-45889https://curecurrent.com/trials/nanocrystalline-megestrol-immunochemo-as-1st-line-for-es-sclc-cachexia-45890https://curecurrent.com/trials/combination-therapy-of-rmc-4630-and-ly3214996-in-metastatic-kras-mutant-cancers-45891https://curecurrent.com/trials/investigating-the-biomarkers-in-tumor-and-peripheral-blood-to-evaluate-the-efficacy-of-cancer-immunotherapy-in-chest-can-45892https://curecurrent.com/trials/f-18-fdg-pet-ct-and-ct-in-initial-staging-of-non-small-lung-cancer-45893https://curecurrent.com/trials/studying-an-investigational-drug-crizotinib-pf-02341066-in-non-non-small-cell-lung-cancer-tumors-that-are-positive-for-a-45894https://curecurrent.com/trials/ai-hope-lung-cancer-building-a-predictive-tool-for-metastatic-lung-cancer-45895https://curecurrent.com/trials/validation-study-on-the-removal-of-epcam-positive-tumour-cells-from-blood-collected-during-tumour-surgery-using-catumaxo-45896https://curecurrent.com/trials/the-impact-of-thoracic-paravertebral-nerve-block-at-different-positions-on-pain-relief-in-patients-undergoing-single-por-45897https://curecurrent.com/trials/a-study-of-atezolizumab-tecentriq-to-investigate-long-term-safety-and-efficacy-in-previously-treated-participants-with-l-45898https://curecurrent.com/trials/nintedanib-plus-egfr-tki-in-egfr-mutated-non-small-cell-lung-cancer-patients-45899https://curecurrent.com/trials/a-safety-and-efficacy-study-of-cc-90011-in-combination-with-nivolumab-in-subjects-with-advanced-cancers-45900https://curecurrent.com/trials/keynatinib-in-treated-patients-with-nsclc-and-brain-metastases-45901https://curecurrent.com/trials/standard-care-with-or-without-early-palliative-care-provided-by-palliative-care-specialist-in-advanced-non-small-cell-lu-45902https://curecurrent.com/trials/a-single-arm-multicenter-prospective-phase-ii-clinical-study-of-apatinib-in-combination-with-adebrelimab-and-ec-regimen-45903https://curecurrent.com/trials/combination-therapy-with-nc-6004-and-gemcitabine-in-advanced-solid-tumors-or-non-small-cell-lung-biliary-and-bladder-can-45904https://curecurrent.com/trials/real-world-study-of-sunvozertinib-treatment-in-advanced-egfr-mutant-nsclc-after-egfr-tki-treatment-failure-45905https://curecurrent.com/trials/a-phase-1-study-of-the-clinical-and-immunologic-effects-of-alt-803-in-patients-with-advanced-solid-tumors-45906https://curecurrent.com/trials/efficacy-and-safety-of-ensartinib-in-neoadjuvant-therapy-for-stage-iia-iiib-operable-or-potentially-operable-alk-positiv-45907https://curecurrent.com/trials/adebrelimab-maintenance-therapy-after-concurrent-chemoradiotherapy-with-hyperfractionated-radiotherapy-in-limited-stage-45908https://curecurrent.com/trials/artificial-intelligence-based-model-for-the-prediction-of-occult-lymph-node-metastasis-and-improvement-of-clinical-decis-45909https://curecurrent.com/trials/a-study-of-yervoy-and-opdivo-combination-therapy-in-participants-with-unresectable-advanced-recurrent-malignant-pleural-45910https://curecurrent.com/trials/a-study-on-the-efficacy-of-atezolizumab-combined-with-chemotherapy-45911https://curecurrent.com/trials/safety-and-efficacy-study-of-first-line-treatment-with-ql1706-plus-chemotherapy-in-extensive-stage-small-cell-lung-cance-45912https://curecurrent.com/trials/first-line-therapy-for-extensive-sclc-patients-treated-with-chemo-keytruda-followed-by-keytuda-trodelvy-45913https://curecurrent.com/trials/neoadjuvant-ensartinib-in-alk-positive-resectable-stage-ii-to-iii-non-small-cell-lung-cancer-45914https://curecurrent.com/trials/adjuvant-treatment-of-alk-positive-non-small-cell-lung-cancer-with-ensartinib-guided-by-mrd-45915https://curecurrent.com/trials/toripalimab-in-combination-with-platinum-plus-etoposidein-patients-with-extensive-stage-small-cell-lung-cancer-45916https://curecurrent.com/trials/ldk378-versus-chemotherapy-in-previously-untreated-patients-with-alk-rearranged-non-small-cell-lung-cancer-45917https://curecurrent.com/trials/acalabrutinib-in-cll-and-mcl-patients-subjected-to-allogeneic-hematopoietic-stem-cell-transplantation-allosct-45918https://curecurrent.com/trials/pneumonitis-in-older-lung-cancer-patients-after-radiotherapy-45919https://curecurrent.com/trials/lcprot-proteomics-longitudinal-cohort-study-on-lung-cancer-45920https://curecurrent.com/trials/evaluation-of-jskn016-in-the-treatment-of-advanced-non-small-cell-lung-cance-a-phase-ii-clinical-study-45921https://curecurrent.com/trials/a-study-of-adebrelimab-in-combination-with-chemo-with-or-without-bevacizumab-neoadjuvant-therapy-for-resectable-nsclc-45922https://curecurrent.com/trials/perioperative-specimen-imaging-using-high-resolution-18f-fdg-pet-ct-during-thoracic-surgery-a-pilot-study-45923https://curecurrent.com/trials/a-clinical-trial-to-evaluate-effect-of-iap0971-in-patients-with-advanced-malignant-tumors-45924https://curecurrent.com/trials/epidemiology-of-abdominal-aortic-aneurysm-with-concomitant-primary-lung-cancer-45925https://curecurrent.com/trials/a-study-of-asp1893-in-adults-with-advanced-cldn6-positive-solid-tumors-45926https://curecurrent.com/trials/comprehensive-demographics-and-clinical-profile-of-nsclc-patients-45927https://curecurrent.com/trials/gain-framed-messages-and-nrt-for-lung-cancer-screening-patients-45928https://curecurrent.com/trials/a-study-to-describe-the-diagnostic-and-therapeutic-path-of-patients-with-nsclc-in-early-stage-and-locally-advanced-45929https://curecurrent.com/trials/adjuvant-adebrelimab-plus-apatinib-after-chemoradiation-in-limited-stage-small-cell-lung-cancer-45930https://curecurrent.com/trials/immunotherapy-in-combination-with-chemoradiation-in-patients-with-advanced-solid-tumors-45931https://curecurrent.com/trials/ccl21-gene-modified-dendritic-cell-vaccine-and-pembrolizumab-in-treating-patients-with-stage-iv-non-small-cell-lung-canc-45932https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-inhaled-corticosteroids-combined-with-bronchodilators-and-programmed-death-ligand-45933https://curecurrent.com/trials/predicting-symptom-trajectories-after-thoracoscopic-lung-cancer-surgery-using-an-interpretable-machine-learning-model-45934https://curecurrent.com/trials/a-dose-escalation-study-of-pf-06939999-in-participants-with-advanced-or-metastatic-solid-tumors-45935https://curecurrent.com/trials/lung-cancer-mutation-consortium-protocol-45936https://curecurrent.com/trials/decoding-the-association-of-imaging-and-tumor-microenvironment-in-lung-cancer-using-radiogenomic-approach-radiogenomics-45937https://curecurrent.com/trials/study-of-durvalumab-following-radiation-therapy-in-patients-with-stage-3-unresectable-nsclc-ineligible-for-chemotherapy-45938https://curecurrent.com/trials/a-phase-ii-study-of-ak112-pd1-vegf-bispecific-in-combination-with-chemotherapy-in-patients-with-nsclc-45939https://curecurrent.com/trials/same-session-mr-only-simulation-and-treatment-with-mri-guided-adaptive-palliative-radiotherapy-45940https://curecurrent.com/trials/a-value-driven-study-on-reducing-immune-checkpoint-inhibitor-dosing-frequency-in-advanced-cancers-45941https://curecurrent.com/trials/a-clinical-trial-of-cea-targeting-car-t-for-cea-positive-advanced-lung-cancer-45942https://curecurrent.com/trials/phase-ii-study-of-ivonescimab-and-cadonilimab-in-combination-with-chemotherapy-in-patients-with-es-sclc-45943https://curecurrent.com/trials/the-accuracy-of-targeted-lymph-node-dissection-of-non-small-cell-lung-cancer-patients-according-to-predictive-models-45944https://curecurrent.com/trials/the-effect-of-beta-glucan-in-non-small-cell-lung-cancer-45945https://curecurrent.com/trials/durvalumab-medi4736-plus-tremelimumab-for-advanced-neuroendocrine-neoplasms-of-gastroenteropancreatic-or-lung-origin-45946https://curecurrent.com/trials/national-comprehensive-cancer-network-nccn-decision-support-tool-for-patients-with-nsclc-45947https://curecurrent.com/trials/universal-cancer-peptide-based-vaccination-in-metastatic-nsclc-45948https://curecurrent.com/trials/a-study-of-dsp107-alone-and-in-combination-with-atezolizumab-for-patients-with-advanced-solid-tumors-45949https://curecurrent.com/trials/ipilimumab-and-nivolumab-in-patients-with-anti-pd-1-axis-therapy-resistant-advanced-non-small-cell-lung-cancer-45950https://curecurrent.com/trials/bupivacaine-liposome-serrate-anterior-plane-block-vs-traditional-thoracic-paravertebral-block-45951https://curecurrent.com/trials/phase-ii-study-of-adebrelimab-chemotherapy-and-apatinib-for-advanced-pulmonary-neuroendocrine-tumors-45952https://curecurrent.com/trials/intratumoral-injection-of-ip-001-following-thermal-ablation-in-patients-with-crc-nsclc-and-sts-45953https://curecurrent.com/trials/frequency-of-pulmonary-toxicity-in-patients-treated-for-hodgkin-lymphoma-45954https://curecurrent.com/trials/partial-pressure-of-oxygen-control-method-in-identification-of-intersegmental-plane-45955https://curecurrent.com/trials/pulmonary-thromboembolism-in-cancer-patients-early-rule-out-from-the-emergency-department-45956https://curecurrent.com/trials/ensartinib-in-the-treatment-of-alk-positive-or-met-exon-14-skipping-anvanced-solid-tumors-excluded-lung-cancer-45957https://curecurrent.com/trials/a-multiple-tumor-species-open-and-multi-center-clinical-study-of-alpaloritovorelli-antibodies-ql-1706-combined-with-puls-45958https://curecurrent.com/trials/durvalumab-plus-chemotherapy-in-untreated-patients-with-extensive-stage-small-cell-lung-cancer-45959https://curecurrent.com/trials/a-study-of-or502-a-monoclonal-antibody-targeting-lilrb2-alone-and-in-combination-with-anticancer-agents-45960https://curecurrent.com/trials/azd9291-osimertinib-versus-platinum-based-doublet-chemotherapy-in-locally-advanced-or-metastatic-non-small-cell-lung-can-45961https://curecurrent.com/trials/fhnd9041-versus-afatinib-for-non-small-cell-lung-cancer-45962https://curecurrent.com/trials/feasibility-of-primer-shot-radiotherapy-for-non-small-cell-lung-cancer-primer-45963https://curecurrent.com/trials/neoadjuvant-befotertinib-combined-bevacizumab-or-platinum-based-double-chemotherapy-for-resectable-locally-advanced-egfr-45964https://curecurrent.com/trials/adebrelimab-plus-apatinib-for-maintenance-therapy-of-extensive-stage-small-cell-lung-cancer-45965https://curecurrent.com/trials/radical-resection-vs-ablative-stereotactic-radiotherapy-in-patients-with-operable-stage-i-nsclc-45966https://curecurrent.com/trials/a-study-to-evaluate-the-value-of-circulating-tumour-dna-in-follow-up-of-patients-with-an-advanced-gastroenteropancreatic-45967https://curecurrent.com/trials/to-evaluate-the-safety-pharmacokinetics-pharmacodynamics-and-antitumor-activity-of-abn401-in-patients-with-advanced-soli-45968https://curecurrent.com/trials/a-study-on-the-efficacy-of-immunotherapy-the-occurrence-and-severity-of-adverse-reactions-in-patients-with-non-small-cel-45969https://curecurrent.com/trials/cryobiopsy-vs-forceps-biopsy-for-peripheral-pulmonary-lesions-45970https://curecurrent.com/trials/dorsal-vetilation-and-ppcs-in-colorectal-cancer-surgery-patients-45971https://curecurrent.com/trials/68ga-grazytracer-pet-ct-for-early-assessment-of-response-to-neoadjuvant-immunotherapy-in-resectable-nsclc-45972https://curecurrent.com/trials/a-study-of-sargramostim-plus-pembrolizumab-with-or-without-pemetrexed-in-patients-with-advance-non-small-cell-lung-cance-45973https://curecurrent.com/trials/prove-queri-project-1-45974https://curecurrent.com/trials/efficacy-study-comparing-zd6474-in-combination-with-pemetrexed-and-pemetrexed-alone-in-2nd-line-nsclc-patients-45975https://curecurrent.com/trials/a-study-of-ty-9591-with-chemotherapy-as-1st-line-treatment-in-patients-with-mutated-epidermal-growth-factor-receptor-nsc-45976https://curecurrent.com/trials/practice-of-oxygenation-and-respiratory-support-during-fiberoptic-bronchoscopy-45977https://curecurrent.com/trials/sunvozertinib-dzd9008-in-pretreated-lung-cancer-patients-with-egfr-exon20-insertion-mutation-wu-kong6-45978https://curecurrent.com/trials/second-line-therapy-for-patients-with-progressive-poorly-differentiated-extra-pulmonary-neuroendocrine-carcinoma-45979https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-al2846-capsule-combined-with-tqb2450-injection-compared-to-docetaxel-injection-45980https://curecurrent.com/trials/liver-directed-rt-chemo-immunotherapy-for-es-sclc-45981https://curecurrent.com/trials/study-of-ty-9591-in-patients-with-a-lung-cancer-with-brain-or-leptomeningeal-metastases-with-egfr-mutation-45982https://curecurrent.com/trials/aumolertinib-versus-osimertinib-as-first-line-therapy-for-patients-with-egfr-mutated-locally-advanced-or-metastatic-non-45983https://curecurrent.com/trials/impact-of-concomitant-use-of-steroids-and-immune-checkpoint-inhibitors-on-survival-outcomes-in-nsclc-patients-45984https://curecurrent.com/trials/efficacy-and-safety-of-sintilimab-combined-with-nab-pp-plus-rh-endostatin-in-locally-advanced-advanced-and-recurrent-met-45985https://curecurrent.com/trials/disitamab-vedotin-in-combination-with-tislelizumab-and-bevacizumab-in-a-phase-ii-clinical-study-of-locally-advanced-or-m-45986https://curecurrent.com/trials/dyadic-psychological-stress-among-lung-cancer-patient-caregiver-dyads-45987https://curecurrent.com/trials/an-exploratory-study-of-tislelizumab-in-combination-with-chemotherapy-in-immuno-experienced-patients-with-egfr-alk-ros1-45988https://curecurrent.com/trials/a-study-of-cm24-in-combination-with-nivolumab-in-adults-with-advanced-solid-tumors-45989https://curecurrent.com/trials/liposomal-irinotecan-and-apatinib-in-es-sclc-45990https://curecurrent.com/trials/treatment-duration-of-ipa-45991https://curecurrent.com/trials/non-interventional-study-for-real-world-data-of-afatinib-treatment-in-first-line-setting-and-of-subsequent-therapies-for-45992https://curecurrent.com/trials/safety-and-durability-of-sirolimus-for-treatment-of-lam-45993https://curecurrent.com/trials/real-world-immuno-radiotherapy-for-advanced-nsclc-45994https://curecurrent.com/trials/ink-cells-as-maintenance-therapy-after-chemoradiotherapy-for-small-cell-lung-cancer-45995https://curecurrent.com/trials/fmt-immunotherapy-chemotherapy-as-first-line-treatment-for-driver-gene-negative-advanced-nsclc-45996https://curecurrent.com/trials/durvalumab-followed-by-chemoradiation-and-consolidation-durvalumab-for-stage-iii-non-small-cell-lung-cancer-45997https://curecurrent.com/trials/durvalumab-medi4736-and-radiosurgery-fsrt-vs-pulsar-for-the-treatment-of-non-small-cell-lung-cancer-brain-metastases-45998https://curecurrent.com/trials/lymph-node-pathologic-grading-strategy-45999https://curecurrent.com/trials/ipilimumab-nivolumab-w-thoracic-radiotherapy-for-extensive-stage-small-cell-lung-cancer-46000